Pleural diseases

Please note:
The material in this section is selected by an automated search.
If these results do not suit your needs, please use the advanced search.
Please note:  Show

 [+]  Congress or journal article abstract The biological effect of intrapleural tissue plasminogen (tPA) activator and DNase delivery in pleural infection patients.
N. Kanellakis (Patras, Greece)
International Congress 2018 - Chinese Programme 2018: Part I - Russian Speaking Programme 2018: Part I - PDW1 Spirometry training programme: become a programme organiser - PG2 Thoracic ultrasound FULLY BOOKED - PG5 Noninvasive ventilation - pitfalls and challenges - PG1 Asthma and chronic obstructive pulmonary disease - PG4 Imaging of the chest - PG7 Sleep-disordered breathing - diagnosis and therapy - PG8 Lung function testing - PG6 Bronchoscopy in pulmonary emergencies - PG9 Chronic obstructive pulmonary disease exacerbations - Primary Care Programme 2018: Part I - PG10 Cystic fibrosis: Basic defects and clinical problems in children  - PG11 Modern approaches in lung cancer diagnostics and therapy - PG3 How to plan for and manage a respiratory epidemic/pandemic - Russian Speaking Programme 2018: Part II - Chinese Programme 2018: Part II - Primary Care Programme 2018: Part II - French Programme 2018: Part I - Spanish and Portuguese Programme 2018: Part I - PG15 Challenging issues in acute interstitial lung diseases - PG12 Interventional pulmonology - PG14 The evolving world of pulmonary rehabilitation - PG16 Advanced cardiopulmonary exercise testing - PG17 Asthma phenotyping - PG13 Challenges in the treatment of tuberculosis - PG18 Cystic fibrosis: management in adult patients - PG19 Heart-lung interaction - French Programme 2018: Part II - Spanish and Portuguese Programme 2018: Part II - CC1 Lung transplantation - CC2 Broad spectrum of chronic thromboembolic pulmonary hypertension - SW1 Body plethysmography - Lung cancer Grand Round - State of the art session: Airways disease - New Sepsis Surviving Campaign guidelines: back to the “art of medicine” - EUREST-PLUS: implementation of the tobacco control policy to reduce lung disease - Difficult paediatric lung disease - ILDs: From bench to bedside - Risk stratification in treatment of pulmonary arterial hypertension - Organoids and pluripotent stem cells  - Respiratory muscles at rest, during exercise and in the critically ill patient - Primary care management of respiratory conditions - Asthma in children and adults: long-term aspects - Prematurity and lung disease - Evolving approaches to differential diagnosis - Epidemiology and prognostication of critically-ill patients - Paediatric asthma: prevention, diagnosis and treatment - The global impact of bronchiectasis and nontuberculous mycobacteria (NTM) - Occupational and environmental lung diseases: asthma and the airways - Evaluation of COPD and various diseases by different imaging modalities - EUS-B and EBUS: optimal utilisation of the EBUS scope - Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities - PDW2 Medical writing - SW5 Endoscopy FULLY BOOKED - SW2 Body plethysmography FULLY BOOKED - Imaging Grand Round - State of the art session: Pulmonary vascular diseases - Cournand lecture: new paradigms in extracorporeal lung assistance - Towards understanding and managing chronic cough - Dyspnoea: a multidimensional and multidisciplinary approach - Imminent global problems in lung cancer require joint action: time for an international alliance! - Mechanisms that underlie exercise limitation in various respiratory diseases - Multidisciplinary approach to ground-glass opacities - Gene-environment interactions in the omics era - Pleural disease: diagnosis, monitoring and management - A fresh view on airway differentiation and regeneration - Cystic fibrosis: microbiological aspects and new treatments - New pharmacological strategies in airway diseases - Challenges in treating tuberculosis and nontuberculous mycobacteria - Clinical news in idiopathic interstitial pneumonias - Assessing pathophysiology in children - COPD phenotypes: a1 antitrypsin deficiency and beyond - Regenerative and anti-fibrotic approaches - Innovative therapies in asthma and COPD - Orphan diseases in children - PDW3 Leading and managing change - Physiological and biological insights in asthma - Asthma: clinical screening tools - Integrated care and non-pharmacological management of COPD - Nutrition and metabolic syndrome in COPD - Cardiovascular morbidities in COPD - COPD around the world - Pharmacological management of COPD - Management of bronchiectasis and large airway diseases - Management of chronic cough and respiratory muscle dysfunction - What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)? - Imaging of various diseases with different imaging modalities - Linear and radial EBUS and peripheral nodules - Pleural interventions - Primary care management of COPD - Functional genomics and COPD: new challenges - Studying novel biomarkers in asthma and COPD - Identification of therapeutic targets for asthma - Pulmonary fibrosis: from models to patients - Pulmonary drug delivery: inhaler use, devices and technologies - New developments in the treatment of asthma - Basic pharmacology - Biomarkers for evaluating COPD - Biomarkers for evaluating asthma - Translational models of the immunopathology that underlies airway obstructive diseases - Role of IgE and interleukin (IL)-5 in Th2-cell signatures - Epidemiology of asthma and allergy: prevalence, incidence and risk factors - Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS) - Occupational and environmental lung diseases: mechanisms, biomarkers and causation - Occupational and environmental lung diseases: influence on the airway and interstitium - Tobacco use and cessation interventions in patients with respiratory, cardiovascular and mental health problems and other populations - Effect of tobacco use on health - Role of omics in population studies - The bad and the ugly in paediatric asthma: comorbidities and exacerbations - Paediatric asthma: new mechanisms and tools - Cystic fibrosis in adults: current research - Clinical problems in paediatric pulmonology - Paediatric bronchology - Molecular and cellular determinants of the developing lung - Respiratory physiology and measurements - Acutely hospitalised patients: physiotherapy interventions and assessment methods - Chronic lung disease : effects of rehabilitation interventions on functional outcomes in patients - Chronic respiratory disease: respiratory muscle function, breathing exercises and airway clearance techniques - Chronic respiratory disease : determinants of physical activity in patients - Chronic respiratory disease: effects of rehabilitation interventions in patients - Contemporary respiratory care: symptoms, the role of the nurse and the organisation of care - Advances in idiopathic pulmonary fibrosis treatment, tracheobronchial reconstruction using bioengineering and clinical prediction rules for diagnosing pulmonary embolism - Interstitial Lung Diseases & Respiratory Infections - ME1 Endoscopic lung volume reduction FULLY BOOKED - ME2 Lung microbiome: study design and standardisation FULLY BOOKED - ME4 Mucus clearance techniques across respiratory care settings - ME3 Bronchoscopic evaluation of recurrent/persistent pneumonia in children - SW6 Endoscopy - SW3 Body plethysmography FULLY BOOKED - PDW4 How to deal with difficult employees and co-workers - Paediatric Year in Review - State of the art session: Sleep and breathing disorders - Current and evolving tests in lung function: pro/con debate - Air pollution and transplantation: near to one's heart and lungs! - Interstitial lung disease: an interdisciplinary approach - Management of pleural infection in 2018 - Best abstracts in pulmonary rehabilitation and chronic care - Cleaning agent exposures: are they really harmful to lung health? - Mitochondrial dysfunction as a driver of lung disease - On the right path: understanding and improving the function of an overloaded right heart ventricle - Educational tools to improve your practice - Novel immunology-based therapies in asthma and COPD - Clinical trials in COPD: new results - New insights in the management of chronic respiratory failure - Variant forms of asthma - Asthma management - Respiratory muscle function, postural control and breathing exercises in chronic respiratory conditions - Systematic reviews on the health effects of emerging tobacco products and electronic nicotine delivery systems (ENDS) - Thoracic surgery, pleural effusions and other general thoracic surgery - Lung cancer: from early diagnosis to modern monitoring strategies - CC3 Lung cancer: personalised treatment and palliative care  - CC4 Tuberculosis - CC5 Pulmonary vasculitis: the great chameleon - SW7 Cardiopulmonary exercise test interpretation - tips and pitfalls FULLY BOOKED - SW10 Thoracic ultrasound FULLY BOOKED - Paediatric Grand Round - State of the art session: Thoracic oncology - Therapeutic breakthroughs Year in Review - New trends in the management of difficult-to-wean patients  - Sleep apnoea: is it time for new therapies? - Rare lung diseases - New modalities in asthma treatment - Pulmonary embolism: what we need to know - Cross-talk in the lung microenvironment: implications for chronic lung disease - COPD and chronic respiratory disease: from misclassification to radiological findings - Novel drug targets for asthma and COPD - Occupational and environmental lung diseases: from early influences and novel exposures to preventative approaches - New developments in tuberculosis - Pleural diseases and pneumonia: what's new ? - Determinants of physical activity behaviour in patients with COPD and the physiotherapist as a physical activity coach  - Integrating pharmacological and non-pharmacological management in COPD: are we there yet? - Clinical determinants and biomarkers of COPD - Improving the outcomes of community-acquired pneumonia - Let’s interact and discuss the hot topics in pulmonary rehabilitation - The many facets of respiratory nursing - SW8 Cardiopulmonary exercise test interpretation - tips and pitfalls FULLY BOOKED - SW11 Thoracic ultrasound FULLY BOOKED - Clinical Year in Review - State of the art session: Respiratory infections - Infectious agents and childhood asthma - Preventing asthma and COPD exacerbations by increasing the inhaled glucocorticoid dose - Integrated care for patients with pulmonary vascular disease, lung diseases and heart failure - Respiratory medicine meets hematology - Intercellular communication in tissue remodelling - COPD: from LABA/ICS to LABA/LAMA/ICS - Cell-matrix interactions in lung disease and regeneration - New predictors of morbidity and mortality in COPD - Respiratory muscles and lung function: from healthy subjects to patients - Granulomatous disorders: epidemiology, genotype and phenotype - Interventional pulmonology highlights in 2018: latest innovations - New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases - Multiomics studies in epidemiology: what can they tell us? - The world of idiopathic pulmonary fibrosis (IPF): global registries - Lung cancer: personalised medicine - New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children - New diagnostic tools for sleep and breathing and healthcare provision options - Respiratory epidemiology: from COPD to factors that associate with lung function and infections - PDW5 Teamability: become an effective team leader and member - Critically ill patients: prognostic factors and biomarkers - Preclinical and clinical studies of critical illness - Muscles and diaphragm, and quality improvement - Non-invasive ventilation for acute respiratory failure - Non-invasive ventilation in chronic respiratory failure - New tools for managing respiratory failure - New methods and concepts in tests of lung and respiratory muscle function - The value of lung function testing in various pathophysiological conditions - Cardiopulmonary exercise testing in COPD and cardiovascular diseases - New methods and concepts in exercise testing - From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS) - Diagnostics including questionnaires - Sleep-disordered breathing: biomarkers and genetics and the role of hypoxia, insomnia, movement disorders and sleep quality - Obesity: comorbidities - Pleural effusions, infections and tumours - Moving lung transplantation forward - Predicting the future: biomarkers of respiratory infection - Pneumonia: from the community to the intensive care unit - Mechanisms of respiratory infection - Improving the quality of life of patients with bronchiectasis - Challenges in tuberculosis care - Tuberculosis comorbidities - Groups who are susceptible to tuberculosis: children, pregnant women and elderly people - Pulmonary tuberculosis: long term complications, rehabilitation and challenges - Lung cancer: new tools for diagnosis and patient assessment - Lung cancer: novel prognostic markers and scores - Lung cancer: modern therapies and beyond - Lung cancer: risk factors, supportive measures and quality improvement - Lung cancer: from the bench to the bedside - Mesothelioma and pleural malignancy: investigations and management - Clinical management of pleural malignancies, including mesothelioma - Consequences of idiopathic interstitial pneumonias - News on the diagnosis of idiopathic interstitial pneumonia - Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF) - CTD-ILD and hypersensitivity pneumonitis:  mechanistic insights and prognostic markers - Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment - Granulomatous disorders: heterogeneous diseases with variable management - Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) - Pulmonary hypertension: therapy - Experimental research in pulmonary hypertension - Clinical aspects of pulmonary hypertension - Pulmonary hypertension in lung diseases and the role of the right ventricle - Diagnosis, prognostication and treatment of pulmonary embolism - Medical education via the web and the internet - COPD, asthma and tuberculosis: benefits related to therapy costs - New biologics for asthma: which patients, which agents, which results, at what cost? - Airway Diseases & Respiratory Infections - Paediatric Respiratory Diseases - ME7 Monitoring of home mechanical ventilation in neuromuscular disorders - PF Occupational lung disease – professional and patient perspectives - ME8 Diagnosing bronchiectasis and cystic fibrosis - ME6 Control of breathing - hypoventilation during sleep, exercise and dyspnoea - ME5 Lung cancer screening - ME14 Bronchiolitis obliterans syndrome in immunodepressed patients - SW9 Cardiopulmonary exercise test interpretation - tips and pitfalls FULLY BOOKED - SW12 Thoracic ultrasound FULLY BOOKED - PDW6 Supporting patients with behaviour change strategies - Chronic pulmonary aspergillosis: from guidelines to real-life implementation - Imaging chronic lung diseases: moving from structure to function  - Idiopathic pulmonary fibrosis diagnosis: new guidelines - Advances in community-acquired pneumonia management  - Roles of innate lymphoid cells in asthma - Microbiomes in respiratory disease - New methods for diagnosing and treating lung diseases - Molecular mechanisms and treatment of pulmonary hypertension - The best of the European Respiratory Journal in 2018 - Pathophysiological aspects of sleep-disordered breathing: intermittent hypoxia - Ventilation and lung imaging in critically ill patients - Lung cancer: new aspects in diagnosis and management - Recent insights in childhood asthma and wheezing - Pulmonary hypertension: right ventricle function, haemodynamics and exercise - Lung transplant science: from primary graft to chronic allograft dysfunction - What’s new in lung function and exercise assessment in COPD? - Exercise is medicine: testing and treating patients with some effort - Cryobiopsy in interstitial lung disease (ILD) - Innovations in equipment and their application - Latest developments in cystic fibrosis - Ensuring impactful independent education - CC6 Interstitial lung diseases  - CC7 Severe asthma - CC8 Non-resolving pneumonia - Pulmonary endoscopy - State of the art session: Respiratory critical care - Proteases: at the cutting edge of lung disease - GINA 2018 and beyond: shaping the future of asthma management - Accelerated ageing in lungs - Prenatal origins of respiratory and atopic disorders - New perspectives on asthma, cough and laryngeal obstruction - Notable Studies in Asthma - Microorganisms and lung ecology: living in peace with bugs - Biomarkers in COPD and asthma - New ideas about respiratory and sleep physiology in children - Acute pulmonary embolism: from diagnosis to treatment - Paediatric respiratory infections: translational and clinical perspectives - Interdependence of COPD and comorbidities and the underlying mechanisms - Muscle adaptations in response to physiotherapeutic interventions in acute and chronic settings - Additional latest insights in pulmonary rehabilitation for chronic lung diseases - CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside - Drug-resistant tuberculosis - Asthma analysis - Novel insights in the basic and translational research on idiopathic interstitial pneumonias - SW19 Clinical interpretation of spirometry results FULLY BOOKED - SW17 Essential skills for the intensive care unit - SW14 Radiological-pathological correlations in different lung diseases for clinicians FULLY BOOKED - Pulmonary endoscopy - Scientific Year in Review - It's my favourite cell that affects your asthma - Recent advances in respiratory disorders with oropharyngeal dysphagia - Fungal infection in the intensive care unit - Recent advances in primary ciliary dyskinesia - Quality, reference values and standards - Progress in rare interstitial lung diseases - New challenges in tackling known diseases with the 10 ERS Principles for Lung Health - Imaging biomarkers and quantitative imaging - Pulmonary embolism: long-term sequelae and advances in therapies  - Novel findings in biomarkers of tobacco use, exposure, hazards and genetics - CTD-ILD and hypersensitivity pneumonitis: risk stratification and management - Telehealth, home rehabilitation and specific adaptations to exercise interventions in different settings - General thoracic surgery - How far are we in terms of predicting mortality and exacerbations in COPD? - Current practices in and attitudes to screening for tuberculosis, and a discussion about genetic diversity - New insights in testing lung and respiratory muscle functions - Asthma and allergy in adults and children and their biomarkers - Pathobiology of pulmonary hypertension - Tests and trends in asthma - Asthma and drugs - Clinical markers of asthma - Patient-reported outcomes and scores in COPD - COPD and extrapulmonary comorbidities - Functional assessment of COPD - Biomarkers of COPD - COPD exacerbations and bronchiectasis - Sarcoidosis, interstitial lung diseases and various clinical problems - Pulmonary rehabilitation: exercise training, body composition, physical activity and other aspects - Aspects of pulmonary rehabilitation and chronic care - Use of stents for tracheal stenosis - Bronchoscopy and transthoracic ultrasound - Primary care management of asthma - Genetics in chronic pulmonary diseases - COPD: immune regulation and therapeutic targets - COPD: novel pathological mechanisms in the airway epithelium - Role of microbial exposure and inflammation in lung injury - Triggers of acute lung injury: mechanical ventilation and oxygen levels - Cardiovascular and metabolic consequences of sleep-disordered breathing - Treatments that can serve as an alternative to positive airway pressure (PAP) - Sleep and breathing control: phenotypes - COPD management - Studies on the mechanisms underlying airway disease - Airway disease: recent discoveries - Clinical and functional monitoring in airway disease - Asthma, rhinitis and COPD: cells, mediators, biomarkers and genetics - Epidemiology of asthma, COPD and factors that associate with lung function - Respiratory epidemiology:  from infectious diseases to lung cancer - Occupational and environmental lung diseases: inhaled air quality and health effects - Epidemiology of the use of traditional and emerging tobacco products and e-cigarettes - Tobacco use, attitudes and cessation training among healthcare professionals and prevention programmes - Improvements in the assessment of paediatric physiology - Paediatric asthma: new insights in its prevalence, treatment and treatment failure - Cystic fibrosis in paediatric patients: current research  - Paediatric respiratory infections: mechanistic insights and clinical outcomes - Neonatology and paediatric intensive care - Insights in primary ciliary dyskinesia, asthma and lung function testing - Clinical challenges in respiratory infection - Difficult-to-treat respiratory infections - The immune response to tuberculosis: development of biomarkers and diagnostic tools - Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis - Diagnosis of tuberculosis - Management of idiopathic interstitial pneumonias: established and new treatments - Back to basics and translational research in idiopathic interstitial pneumonias - Bronchiectasis: new insights in diagnosis and treatment - Sleep and Breathing Disorders - Myths and Truths of Inhaler Technology - Respiratory Infections - ME9 Cryobiopsy in interstitial lung disease FULLY BOOKED - Pulmonary Vascular Diseases & Respiratory Infections - ME11 Management of severe asthma in children - ME10 Pulmonary arterial hypertension: treatment options FULLY BOOKED - ME12 Immunotherapies for lung cancer - ME13 Management of pulmonary and critical care disease during pregnancy - SW20 Clinical interpretation of spirometry results - SW18 Essential skills for the intensive care unit - SW15 Radiological-pathological correlations in different lung diseases for clinicians - Clinical Grand Round  - State of the art session: Interstitial lung diseases - The digital ®evolution in respiratory medicine: a personalised approach? - Pathophysiology of the human lung alveolus - Emerging tobacco products and harm reduction: a tobacco solution to a tobacco problem? - Lung cancer screening and management of solitary pulmonary nodules - Advanced profiling of immune cells in chronic lung diseases - Interventional pulmonology highlights in 2018: ELVR, TLD and BT - Malignant pleural effusions - Chronic thromboembolic pulmonary hypertension - Bronchiectasis: phenotypes, endotypes and new therapies - Early Career Member: career and opportunities - Epidemiology, phenotypes and cardiometabolic comorbidities of obstructive sleep apnoea - Disease exacerbations from a molecular point of view - Cystic fibrosis: diagnosis and monitoring - Understanding the immunopathology that underlies airway obstructive diseases - Primary ciliary dyskinesia and lung function tests in respiratory morbidities - Clinical determinants of asthma and biomarkers - Biomarkers and lung function in airway disease - Occupational and environmental lung diseases: air quality and lung damage - State of the art session: Paediatric respiratory diseases - New trends in the management of pulmonary hypertension - Respiratory medicine meets rheumatology - New drugs, strategies and research designs for advanced non-small cell lung cancer - The complexities of managing mild asthma - Does asthma phenotyping improve treatment? - New determinants of cardiovascular morbidity in COPD - Antimicrobial host defence and innate immunity in the lung - Novel and established imaging studies and findings - Effect of environmental exposure on lung function outcomes - Physiotherapy care for patients with acute and chronic respiratory conditions - Latest advances in pulmonary rehabilitation assessment and content - Sarcoidosis: from basic research to patient outcomes - Innovative tobacco cessation approaches and trends in tobacco and e-cigarette use - What is new in idiopathic interstitial pneumonias? - Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control - Tuberculosis transmission and screening strategies - The importance of the pulmonary function test in different clinical settings - The airway microbiome across the spectrum of airway disease - The asthma-allergy “family”  - Important changes in the management of tuberculosis - Endoscopic solutions for obstructive lung diseases - Palliative care specific for respiratory diseases - Emerging and novel imaging biomarkers in drug-induced interstitial lung disease - Advances in exercise physiopathology - New insights in the signalling pathways that underlie IPF pathophysiology - Effects of smoking on asthma - Progress in basic and translational research on idiopathic interstitial pneumonias - Upper airways morphology and diagnostics, and the challenges associated with mandibular advancement - Lung cancer: novel molecular markers and mechanisms - Eosinophils in airway disease - Endoscopic lung volume reduction - Hot topics in non-invasive ventilation - Exploring the importance of daily physical activity in chronic respiratory disease - New developments in paediatric asthma - New therapies for respiratory infections: experimental and translational studies See this session or publication
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract Pneumothorax after Bronchoscopic Lung Volume Reduction with Endobronchial Valves(EBV-BLVR): Is there any correlation with number of valves?
V. Luzzi (Firenze (FI), Italy)
International Congress 2018 - Chinese Programme 2018: Part I - Russian Speaking Programme 2018: Part I - PDW1 Spirometry training programme: become a programme organiser - PG2 Thoracic ultrasound FULLY BOOKED - PG5 Noninvasive ventilation - pitfalls and challenges - PG1 Asthma and chronic obstructive pulmonary disease - PG4 Imaging of the chest - PG7 Sleep-disordered breathing - diagnosis and therapy - PG8 Lung function testing - PG6 Bronchoscopy in pulmonary emergencies - PG9 Chronic obstructive pulmonary disease exacerbations - Primary Care Programme 2018: Part I - PG10 Cystic fibrosis: Basic defects and clinical problems in children  - PG11 Modern approaches in lung cancer diagnostics and therapy - PG3 How to plan for and manage a respiratory epidemic/pandemic - Russian Speaking Programme 2018: Part II - Chinese Programme 2018: Part II - Primary Care Programme 2018: Part II - French Programme 2018: Part I - Spanish and Portuguese Programme 2018: Part I - PG15 Challenging issues in acute interstitial lung diseases - PG12 Interventional pulmonology - PG14 The evolving world of pulmonary rehabilitation - PG16 Advanced cardiopulmonary exercise testing - PG17 Asthma phenotyping - PG13 Challenges in the treatment of tuberculosis - PG18 Cystic fibrosis: management in adult patients - PG19 Heart-lung interaction - French Programme 2018: Part II - Spanish and Portuguese Programme 2018: Part II - CC1 Lung transplantation - CC2 Broad spectrum of chronic thromboembolic pulmonary hypertension - SW1 Body plethysmography - Lung cancer Grand Round - State of the art session: Airways disease - New Sepsis Surviving Campaign guidelines: back to the “art of medicine” - EUREST-PLUS: implementation of the tobacco control policy to reduce lung disease - Difficult paediatric lung disease - ILDs: From bench to bedside - Risk stratification in treatment of pulmonary arterial hypertension - Organoids and pluripotent stem cells  - Respiratory muscles at rest, during exercise and in the critically ill patient - Primary care management of respiratory conditions - Asthma in children and adults: long-term aspects - Prematurity and lung disease - Evolving approaches to differential diagnosis - Epidemiology and prognostication of critically-ill patients - Paediatric asthma: prevention, diagnosis and treatment - The global impact of bronchiectasis and nontuberculous mycobacteria (NTM) - Occupational and environmental lung diseases: asthma and the airways - Evaluation of COPD and various diseases by different imaging modalities - EUS-B and EBUS: optimal utilisation of the EBUS scope - Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities - PDW2 Medical writing - SW5 Endoscopy FULLY BOOKED - SW2 Body plethysmography FULLY BOOKED - Imaging Grand Round - State of the art session: Pulmonary vascular diseases - Cournand lecture: new paradigms in extracorporeal lung assistance - Towards understanding and managing chronic cough - Dyspnoea: a multidimensional and multidisciplinary approach - Imminent global problems in lung cancer require joint action: time for an international alliance! - Mechanisms that underlie exercise limitation in various respiratory diseases - Multidisciplinary approach to ground-glass opacities - Gene-environment interactions in the omics era - Pleural disease: diagnosis, monitoring and management - A fresh view on airway differentiation and regeneration - Cystic fibrosis: microbiological aspects and new treatments - New pharmacological strategies in airway diseases - Challenges in treating tuberculosis and nontuberculous mycobacteria - Clinical news in idiopathic interstitial pneumonias - Assessing pathophysiology in children - COPD phenotypes: a1 antitrypsin deficiency and beyond - Regenerative and anti-fibrotic approaches - Innovative therapies in asthma and COPD - Orphan diseases in children - PDW3 Leading and managing change - Physiological and biological insights in asthma - Asthma: clinical screening tools - Integrated care and non-pharmacological management of COPD - Nutrition and metabolic syndrome in COPD - Cardiovascular morbidities in COPD - COPD around the world - Pharmacological management of COPD - Management of bronchiectasis and large airway diseases - Management of chronic cough and respiratory muscle dysfunction - What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)? - Imaging of various diseases with different imaging modalities - Linear and radial EBUS and peripheral nodules - Pleural interventions - Primary care management of COPD - Functional genomics and COPD: new challenges - Studying novel biomarkers in asthma and COPD - Identification of therapeutic targets for asthma - Pulmonary fibrosis: from models to patients - Pulmonary drug delivery: inhaler use, devices and technologies - New developments in the treatment of asthma - Basic pharmacology - Biomarkers for evaluating COPD - Biomarkers for evaluating asthma - Translational models of the immunopathology that underlies airway obstructive diseases - Role of IgE and interleukin (IL)-5 in Th2-cell signatures - Epidemiology of asthma and allergy: prevalence, incidence and risk factors - Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS) - Occupational and environmental lung diseases: mechanisms, biomarkers and causation - Occupational and environmental lung diseases: influence on the airway and interstitium - Tobacco use and cessation interventions in patients with respiratory, cardiovascular and mental health problems and other populations - Effect of tobacco use on health - Role of omics in population studies - The bad and the ugly in paediatric asthma: comorbidities and exacerbations - Paediatric asthma: new mechanisms and tools - Cystic fibrosis in adults: current research - Clinical problems in paediatric pulmonology - Paediatric bronchology - Molecular and cellular determinants of the developing lung - Respiratory physiology and measurements - Acutely hospitalised patients: physiotherapy interventions and assessment methods - Chronic lung disease : effects of rehabilitation interventions on functional outcomes in patients - Chronic respiratory disease: respiratory muscle function, breathing exercises and airway clearance techniques - Chronic respiratory disease : determinants of physical activity in patients - Chronic respiratory disease: effects of rehabilitation interventions in patients - Contemporary respiratory care: symptoms, the role of the nurse and the organisation of care - Advances in idiopathic pulmonary fibrosis treatment, tracheobronchial reconstruction using bioengineering and clinical prediction rules for diagnosing pulmonary embolism - Interstitial Lung Diseases & Respiratory Infections - ME1 Endoscopic lung volume reduction FULLY BOOKED - ME2 Lung microbiome: study design and standardisation FULLY BOOKED - ME4 Mucus clearance techniques across respiratory care settings - ME3 Bronchoscopic evaluation of recurrent/persistent pneumonia in children - SW6 Endoscopy - SW3 Body plethysmography FULLY BOOKED - PDW4 How to deal with difficult employees and co-workers - Paediatric Year in Review - State of the art session: Sleep and breathing disorders - Current and evolving tests in lung function: pro/con debate - Air pollution and transplantation: near to one's heart and lungs! - Interstitial lung disease: an interdisciplinary approach - Management of pleural infection in 2018 - Best abstracts in pulmonary rehabilitation and chronic care - Cleaning agent exposures: are they really harmful to lung health? - Mitochondrial dysfunction as a driver of lung disease - On the right path: understanding and improving the function of an overloaded right heart ventricle - Educational tools to improve your practice - Novel immunology-based therapies in asthma and COPD - Clinical trials in COPD: new results - New insights in the management of chronic respiratory failure - Variant forms of asthma - Asthma management - Respiratory muscle function, postural control and breathing exercises in chronic respiratory conditions - Systematic reviews on the health effects of emerging tobacco products and electronic nicotine delivery systems (ENDS) - Thoracic surgery, pleural effusions and other general thoracic surgery - Lung cancer: from early diagnosis to modern monitoring strategies - CC3 Lung cancer: personalised treatment and palliative care  - CC4 Tuberculosis - CC5 Pulmonary vasculitis: the great chameleon - SW7 Cardiopulmonary exercise test interpretation - tips and pitfalls FULLY BOOKED - SW10 Thoracic ultrasound FULLY BOOKED - Paediatric Grand Round - State of the art session: Thoracic oncology - Therapeutic breakthroughs Year in Review - New trends in the management of difficult-to-wean patients  - Sleep apnoea: is it time for new therapies? - Rare lung diseases - New modalities in asthma treatment - Pulmonary embolism: what we need to know - Cross-talk in the lung microenvironment: implications for chronic lung disease - COPD and chronic respiratory disease: from misclassification to radiological findings - Novel drug targets for asthma and COPD - Occupational and environmental lung diseases: from early influences and novel exposures to preventative approaches - New developments in tuberculosis - Pleural diseases and pneumonia: what's new ? - Determinants of physical activity behaviour in patients with COPD and the physiotherapist as a physical activity coach  - Integrating pharmacological and non-pharmacological management in COPD: are we there yet? - Clinical determinants and biomarkers of COPD - Improving the outcomes of community-acquired pneumonia - Let’s interact and discuss the hot topics in pulmonary rehabilitation - The many facets of respiratory nursing - SW8 Cardiopulmonary exercise test interpretation - tips and pitfalls FULLY BOOKED - SW11 Thoracic ultrasound FULLY BOOKED - Clinical Year in Review - State of the art session: Respiratory infections - Infectious agents and childhood asthma - Preventing asthma and COPD exacerbations by increasing the inhaled glucocorticoid dose - Integrated care for patients with pulmonary vascular disease, lung diseases and heart failure - Respiratory medicine meets hematology - Intercellular communication in tissue remodelling - COPD: from LABA/ICS to LABA/LAMA/ICS - Cell-matrix interactions in lung disease and regeneration - New predictors of morbidity and mortality in COPD - Respiratory muscles and lung function: from healthy subjects to patients - Granulomatous disorders: epidemiology, genotype and phenotype - Interventional pulmonology highlights in 2018: latest innovations - New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases - Multiomics studies in epidemiology: what can they tell us? - The world of idiopathic pulmonary fibrosis (IPF): global registries - Lung cancer: personalised medicine - New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children - New diagnostic tools for sleep and breathing and healthcare provision options - Respiratory epidemiology: from COPD to factors that associate with lung function and infections - PDW5 Teamability: become an effective team leader and member - Critically ill patients: prognostic factors and biomarkers - Preclinical and clinical studies of critical illness - Muscles and diaphragm, and quality improvement - Non-invasive ventilation for acute respiratory failure - Non-invasive ventilation in chronic respiratory failure - New tools for managing respiratory failure - New methods and concepts in tests of lung and respiratory muscle function - The value of lung function testing in various pathophysiological conditions - Cardiopulmonary exercise testing in COPD and cardiovascular diseases - New methods and concepts in exercise testing - From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS) - Diagnostics including questionnaires - Sleep-disordered breathing: biomarkers and genetics and the role of hypoxia, insomnia, movement disorders and sleep quality - Obesity: comorbidities - Pleural effusions, infections and tumours - Moving lung transplantation forward - Predicting the future: biomarkers of respiratory infection - Pneumonia: from the community to the intensive care unit - Mechanisms of respiratory infection - Improving the quality of life of patients with bronchiectasis - Challenges in tuberculosis care - Tuberculosis comorbidities - Groups who are susceptible to tuberculosis: children, pregnant women and elderly people - Pulmonary tuberculosis: long term complications, rehabilitation and challenges - Lung cancer: new tools for diagnosis and patient assessment - Lung cancer: novel prognostic markers and scores - Lung cancer: modern therapies and beyond - Lung cancer: risk factors, supportive measures and quality improvement - Lung cancer: from the bench to the bedside - Mesothelioma and pleural malignancy: investigations and management - Clinical management of pleural malignancies, including mesothelioma - Consequences of idiopathic interstitial pneumonias - News on the diagnosis of idiopathic interstitial pneumonia - Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF) - CTD-ILD and hypersensitivity pneumonitis:  mechanistic insights and prognostic markers - Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment - Granulomatous disorders: heterogeneous diseases with variable management - Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) - Pulmonary hypertension: therapy - Experimental research in pulmonary hypertension - Clinical aspects of pulmonary hypertension - Pulmonary hypertension in lung diseases and the role of the right ventricle - Diagnosis, prognostication and treatment of pulmonary embolism - Medical education via the web and the internet - COPD, asthma and tuberculosis: benefits related to therapy costs - New biologics for asthma: which patients, which agents, which results, at what cost? - Airway Diseases & Respiratory Infections - Paediatric Respiratory Diseases - ME7 Monitoring of home mechanical ventilation in neuromuscular disorders - PF Occupational lung disease – professional and patient perspectives - ME8 Diagnosing bronchiectasis and cystic fibrosis - ME6 Control of breathing - hypoventilation during sleep, exercise and dyspnoea - ME5 Lung cancer screening - ME14 Bronchiolitis obliterans syndrome in immunodepressed patients - SW9 Cardiopulmonary exercise test interpretation - tips and pitfalls FULLY BOOKED - SW12 Thoracic ultrasound FULLY BOOKED - PDW6 Supporting patients with behaviour change strategies - Chronic pulmonary aspergillosis: from guidelines to real-life implementation - Imaging chronic lung diseases: moving from structure to function  - Idiopathic pulmonary fibrosis diagnosis: new guidelines - Advances in community-acquired pneumonia management  - Roles of innate lymphoid cells in asthma - Microbiomes in respiratory disease - New methods for diagnosing and treating lung diseases - Molecular mechanisms and treatment of pulmonary hypertension - The best of the European Respiratory Journal in 2018 - Pathophysiological aspects of sleep-disordered breathing: intermittent hypoxia - Ventilation and lung imaging in critically ill patients - Lung cancer: new aspects in diagnosis and management - Recent insights in childhood asthma and wheezing - Pulmonary hypertension: right ventricle function, haemodynamics and exercise - Lung transplant science: from primary graft to chronic allograft dysfunction - What’s new in lung function and exercise assessment in COPD? - Exercise is medicine: testing and treating patients with some effort - Cryobiopsy in interstitial lung disease (ILD) - Innovations in equipment and their application - Latest developments in cystic fibrosis - Ensuring impactful independent education - CC6 Interstitial lung diseases  - CC7 Severe asthma - CC8 Non-resolving pneumonia - Pulmonary endoscopy - State of the art session: Respiratory critical care - Proteases: at the cutting edge of lung disease - GINA 2018 and beyond: shaping the future of asthma management - Accelerated ageing in lungs - Prenatal origins of respiratory and atopic disorders - New perspectives on asthma, cough and laryngeal obstruction - Notable Studies in Asthma - Microorganisms and lung ecology: living in peace with bugs - Biomarkers in COPD and asthma - New ideas about respiratory and sleep physiology in children - Acute pulmonary embolism: from diagnosis to treatment - Paediatric respiratory infections: translational and clinical perspectives - Interdependence of COPD and comorbidities and the underlying mechanisms - Muscle adaptations in response to physiotherapeutic interventions in acute and chronic settings - Additional latest insights in pulmonary rehabilitation for chronic lung diseases - CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside - Drug-resistant tuberculosis - Asthma analysis - Novel insights in the basic and translational research on idiopathic interstitial pneumonias - SW19 Clinical interpretation of spirometry results FULLY BOOKED - SW17 Essential skills for the intensive care unit - SW14 Radiological-pathological correlations in different lung diseases for clinicians FULLY BOOKED - Pulmonary endoscopy - Scientific Year in Review - It's my favourite cell that affects your asthma - Recent advances in respiratory disorders with oropharyngeal dysphagia - Fungal infection in the intensive care unit - Recent advances in primary ciliary dyskinesia - Quality, reference values and standards - Progress in rare interstitial lung diseases - New challenges in tackling known diseases with the 10 ERS Principles for Lung Health - Imaging biomarkers and quantitative imaging - Pulmonary embolism: long-term sequelae and advances in therapies  - Novel findings in biomarkers of tobacco use, exposure, hazards and genetics - CTD-ILD and hypersensitivity pneumonitis: risk stratification and management - Telehealth, home rehabilitation and specific adaptations to exercise interventions in different settings - General thoracic surgery - How far are we in terms of predicting mortality and exacerbations in COPD? - Current practices in and attitudes to screening for tuberculosis, and a discussion about genetic diversity - New insights in testing lung and respiratory muscle functions - Asthma and allergy in adults and children and their biomarkers - Pathobiology of pulmonary hypertension - Tests and trends in asthma - Asthma and drugs - Clinical markers of asthma - Patient-reported outcomes and scores in COPD - COPD and extrapulmonary comorbidities - Functional assessment of COPD - Biomarkers of COPD - COPD exacerbations and bronchiectasis - Sarcoidosis, interstitial lung diseases and various clinical problems - Pulmonary rehabilitation: exercise training, body composition, physical activity and other aspects - Aspects of pulmonary rehabilitation and chronic care - Use of stents for tracheal stenosis - Bronchoscopy and transthoracic ultrasound - Primary care management of asthma - Genetics in chronic pulmonary diseases - COPD: immune regulation and therapeutic targets - COPD: novel pathological mechanisms in the airway epithelium - Role of microbial exposure and inflammation in lung injury - Triggers of acute lung injury: mechanical ventilation and oxygen levels - Cardiovascular and metabolic consequences of sleep-disordered breathing - Treatments that can serve as an alternative to positive airway pressure (PAP) - Sleep and breathing control: phenotypes - COPD management - Studies on the mechanisms underlying airway disease - Airway disease: recent discoveries - Clinical and functional monitoring in airway disease - Asthma, rhinitis and COPD: cells, mediators, biomarkers and genetics - Epidemiology of asthma, COPD and factors that associate with lung function - Respiratory epidemiology:  from infectious diseases to lung cancer - Occupational and environmental lung diseases: inhaled air quality and health effects - Epidemiology of the use of traditional and emerging tobacco products and e-cigarettes - Tobacco use, attitudes and cessation training among healthcare professionals and prevention programmes - Improvements in the assessment of paediatric physiology - Paediatric asthma: new insights in its prevalence, treatment and treatment failure - Cystic fibrosis in paediatric patients: current research  - Paediatric respiratory infections: mechanistic insights and clinical outcomes - Neonatology and paediatric intensive care - Insights in primary ciliary dyskinesia, asthma and lung function testing - Clinical challenges in respiratory infection - Difficult-to-treat respiratory infections - The immune response to tuberculosis: development of biomarkers and diagnostic tools - Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis - Diagnosis of tuberculosis - Management of idiopathic interstitial pneumonias: established and new treatments - Back to basics and translational research in idiopathic interstitial pneumonias - Bronchiectasis: new insights in diagnosis and treatment - Sleep and Breathing Disorders - Myths and Truths of Inhaler Technology - Respiratory Infections - ME9 Cryobiopsy in interstitial lung disease FULLY BOOKED - Pulmonary Vascular Diseases & Respiratory Infections - ME11 Management of severe asthma in children - ME10 Pulmonary arterial hypertension: treatment options FULLY BOOKED - ME12 Immunotherapies for lung cancer - ME13 Management of pulmonary and critical care disease during pregnancy - SW20 Clinical interpretation of spirometry results - SW18 Essential skills for the intensive care unit - SW15 Radiological-pathological correlations in different lung diseases for clinicians - Clinical Grand Round  - State of the art session: Interstitial lung diseases - The digital ®evolution in respiratory medicine: a personalised approach? - Pathophysiology of the human lung alveolus - Emerging tobacco products and harm reduction: a tobacco solution to a tobacco problem? - Lung cancer screening and management of solitary pulmonary nodules - Advanced profiling of immune cells in chronic lung diseases - Interventional pulmonology highlights in 2018: ELVR, TLD and BT - Malignant pleural effusions - Chronic thromboembolic pulmonary hypertension - Bronchiectasis: phenotypes, endotypes and new therapies - Early Career Member: career and opportunities - Epidemiology, phenotypes and cardiometabolic comorbidities of obstructive sleep apnoea - Disease exacerbations from a molecular point of view - Cystic fibrosis: diagnosis and monitoring - Understanding the immunopathology that underlies airway obstructive diseases - Primary ciliary dyskinesia and lung function tests in respiratory morbidities - Clinical determinants of asthma and biomarkers - Biomarkers and lung function in airway disease - Occupational and environmental lung diseases: air quality and lung damage - State of the art session: Paediatric respiratory diseases - New trends in the management of pulmonary hypertension - Respiratory medicine meets rheumatology - New drugs, strategies and research designs for advanced non-small cell lung cancer - The complexities of managing mild asthma - Does asthma phenotyping improve treatment? - New determinants of cardiovascular morbidity in COPD - Antimicrobial host defence and innate immunity in the lung - Novel and established imaging studies and findings - Effect of environmental exposure on lung function outcomes - Physiotherapy care for patients with acute and chronic respiratory conditions - Latest advances in pulmonary rehabilitation assessment and content - Sarcoidosis: from basic research to patient outcomes - Innovative tobacco cessation approaches and trends in tobacco and e-cigarette use - What is new in idiopathic interstitial pneumonias? - Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control - Tuberculosis transmission and screening strategies - The importance of the pulmonary function test in different clinical settings - The airway microbiome across the spectrum of airway disease - The asthma-allergy “family”  - Important changes in the management of tuberculosis - Endoscopic solutions for obstructive lung diseases - Palliative care specific for respiratory diseases - Emerging and novel imaging biomarkers in drug-induced interstitial lung disease - Advances in exercise physiopathology - New insights in the signalling pathways that underlie IPF pathophysiology - Effects of smoking on asthma - Progress in basic and translational research on idiopathic interstitial pneumonias - Upper airways morphology and diagnostics, and the challenges associated with mandibular advancement - Lung cancer: novel molecular markers and mechanisms - Eosinophils in airway disease - Endoscopic lung volume reduction See this session or publication
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract Endobronchial valves and spigots in a non-standard indication
H. Bartáková (Praha, Czech Republic)
International Congress 2018 - Chinese Programme 2018: Part I - Russian Speaking Programme 2018: Part I - PDW1 Spirometry training programme: become a programme organiser - PG2 Thoracic ultrasound FULLY BOOKED - PG5 Noninvasive ventilation - pitfalls and challenges - PG1 Asthma and chronic obstructive pulmonary disease - PG4 Imaging of the chest - PG7 Sleep-disordered breathing - diagnosis and therapy - PG8 Lung function testing - PG6 Bronchoscopy in pulmonary emergencies - PG9 Chronic obstructive pulmonary disease exacerbations - Primary Care Programme 2018: Part I - PG10 Cystic fibrosis: Basic defects and clinical problems in children  - PG11 Modern approaches in lung cancer diagnostics and therapy - PG3 How to plan for and manage a respiratory epidemic/pandemic - Russian Speaking Programme 2018: Part II - Chinese Programme 2018: Part II - Primary Care Programme 2018: Part II - French Programme 2018: Part I - Spanish and Portuguese Programme 2018: Part I - PG15 Challenging issues in acute interstitial lung diseases - PG12 Interventional pulmonology - PG14 The evolving world of pulmonary rehabilitation - PG16 Advanced cardiopulmonary exercise testing - PG17 Asthma phenotyping - PG13 Challenges in the treatment of tuberculosis - PG18 Cystic fibrosis: management in adult patients - PG19 Heart-lung interaction - French Programme 2018: Part II - Spanish and Portuguese Programme 2018: Part II - CC1 Lung transplantation - CC2 Broad spectrum of chronic thromboembolic pulmonary hypertension - SW1 Body plethysmography - Lung cancer Grand Round - State of the art session: Airways disease - New Sepsis Surviving Campaign guidelines: back to the “art of medicine” - EUREST-PLUS: implementation of the tobacco control policy to reduce lung disease - Difficult paediatric lung disease - ILDs: From bench to bedside - Risk stratification in treatment of pulmonary arterial hypertension - Organoids and pluripotent stem cells  - Respiratory muscles at rest, during exercise and in the critically ill patient - Primary care management of respiratory conditions - Asthma in children and adults: long-term aspects - Prematurity and lung disease - Evolving approaches to differential diagnosis - Epidemiology and prognostication of critically-ill patients - Paediatric asthma: prevention, diagnosis and treatment - The global impact of bronchiectasis and nontuberculous mycobacteria (NTM) - Occupational and environmental lung diseases: asthma and the airways - Evaluation of COPD and various diseases by different imaging modalities - EUS-B and EBUS: optimal utilisation of the EBUS scope - Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities - PDW2 Medical writing - SW5 Endoscopy FULLY BOOKED - SW2 Body plethysmography FULLY BOOKED - Imaging Grand Round - State of the art session: Pulmonary vascular diseases - Cournand lecture: new paradigms in extracorporeal lung assistance - Towards understanding and managing chronic cough - Dyspnoea: a multidimensional and multidisciplinary approach - Imminent global problems in lung cancer require joint action: time for an international alliance! - Mechanisms that underlie exercise limitation in various respiratory diseases - Multidisciplinary approach to ground-glass opacities - Gene-environment interactions in the omics era - Pleural disease: diagnosis, monitoring and management - A fresh view on airway differentiation and regeneration - Cystic fibrosis: microbiological aspects and new treatments - New pharmacological strategies in airway diseases - Challenges in treating tuberculosis and nontuberculous mycobacteria - Clinical news in idiopathic interstitial pneumonias - Assessing pathophysiology in children - COPD phenotypes: a1 antitrypsin deficiency and beyond - Regenerative and anti-fibrotic approaches - Innovative therapies in asthma and COPD - Orphan diseases in children - PDW3 Leading and managing change - Physiological and biological insights in asthma - Asthma: clinical screening tools - Integrated care and non-pharmacological management of COPD - Nutrition and metabolic syndrome in COPD - Cardiovascular morbidities in COPD - COPD around the world - Pharmacological management of COPD - Management of bronchiectasis and large airway diseases - Management of chronic cough and respiratory muscle dysfunction - What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)? - Imaging of various diseases with different imaging modalities - Linear and radial EBUS and peripheral nodules - Pleural interventions - Primary care management of COPD - Functional genomics and COPD: new challenges - Studying novel biomarkers in asthma and COPD - Identification of therapeutic targets for asthma - Pulmonary fibrosis: from models to patients - Pulmonary drug delivery: inhaler use, devices and technologies - New developments in the treatment of asthma - Basic pharmacology - Biomarkers for evaluating COPD - Biomarkers for evaluating asthma - Translational models of the immunopathology that underlies airway obstructive diseases - Role of IgE and interleukin (IL)-5 in Th2-cell signatures - Epidemiology of asthma and allergy: prevalence, incidence and risk factors - Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS) - Occupational and environmental lung diseases: mechanisms, biomarkers and causation - Occupational and environmental lung diseases: influence on the airway and interstitium - Tobacco use and cessation interventions in patients with respiratory, cardiovascular and mental health problems and other populations - Effect of tobacco use on health - Role of omics in population studies - The bad and the ugly in paediatric asthma: comorbidities and exacerbations - Paediatric asthma: new mechanisms and tools - Cystic fibrosis in adults: current research - Clinical problems in paediatric pulmonology - Paediatric bronchology - Molecular and cellular determinants of the developing lung - Respiratory physiology and measurements - Acutely hospitalised patients: physiotherapy interventions and assessment methods - Chronic lung disease : effects of rehabilitation interventions on functional outcomes in patients - Chronic respiratory disease: respiratory muscle function, breathing exercises and airway clearance techniques - Chronic respiratory disease : determinants of physical activity in patients - Chronic respiratory disease: effects of rehabilitation interventions in patients - Contemporary respiratory care: symptoms, the role of the nurse and the organisation of care - Advances in idiopathic pulmonary fibrosis treatment, tracheobronchial reconstruction using bioengineering and clinical prediction rules for diagnosing pulmonary embolism - Interstitial Lung Diseases & Respiratory Infections - ME1 Endoscopic lung volume reduction FULLY BOOKED - ME2 Lung microbiome: study design and standardisation FULLY BOOKED - ME4 Mucus clearance techniques across respiratory care settings - ME3 Bronchoscopic evaluation of recurrent/persistent pneumonia in children - SW6 Endoscopy - SW3 Body plethysmography FULLY BOOKED - PDW4 How to deal with difficult employees and co-workers - Paediatric Year in Review - State of the art session: Sleep and breathing disorders - Current and evolving tests in lung function: pro/con debate - Air pollution and transplantation: near to one's heart and lungs! - Interstitial lung disease: an interdisciplinary approach - Management of pleural infection in 2018 - Best abstracts in pulmonary rehabilitation and chronic care - Cleaning agent exposures: are they really harmful to lung health? - Mitochondrial dysfunction as a driver of lung disease - On the right path: understanding and improving the function of an overloaded right heart ventricle - Educational tools to improve your practice - Novel immunology-based therapies in asthma and COPD - Clinical trials in COPD: new results - New insights in the management of chronic respiratory failure - Variant forms of asthma - Asthma management - Respiratory muscle function, postural control and breathing exercises in chronic respiratory conditions - Systematic reviews on the health effects of emerging tobacco products and electronic nicotine delivery systems (ENDS) - Thoracic surgery, pleural effusions and other general thoracic surgery - Lung cancer: from early diagnosis to modern monitoring strategies - CC3 Lung cancer: personalised treatment and palliative care  - CC4 Tuberculosis - CC5 Pulmonary vasculitis: the great chameleon - SW7 Cardiopulmonary exercise test interpretation - tips and pitfalls FULLY BOOKED - SW10 Thoracic ultrasound FULLY BOOKED - Paediatric Grand Round - State of the art session: Thoracic oncology - Therapeutic breakthroughs Year in Review - New trends in the management of difficult-to-wean patients  - Sleep apnoea: is it time for new therapies? - Rare lung diseases - New modalities in asthma treatment - Pulmonary embolism: what we need to know - Cross-talk in the lung microenvironment: implications for chronic lung disease - COPD and chronic respiratory disease: from misclassification to radiological findings - Novel drug targets for asthma and COPD - Occupational and environmental lung diseases: from early influences and novel exposures to preventative approaches - New developments in tuberculosis - Pleural diseases and pneumonia: what's new ? - Determinants of physical activity behaviour in patients with COPD and the physiotherapist as a physical activity coach  - Integrating pharmacological and non-pharmacological management in COPD: are we there yet? - Clinical determinants and biomarkers of COPD - Improving the outcomes of community-acquired pneumonia - Let’s interact and discuss the hot topics in pulmonary rehabilitation - The many facets of respiratory nursing - SW8 Cardiopulmonary exercise test interpretation - tips and pitfalls FULLY BOOKED - SW11 Thoracic ultrasound FULLY BOOKED - Clinical Year in Review - State of the art session: Respiratory infections - Infectious agents and childhood asthma - Preventing asthma and COPD exacerbations by increasing the inhaled glucocorticoid dose - Integrated care for patients with pulmonary vascular disease, lung diseases and heart failure - Respiratory medicine meets hematology - Intercellular communication in tissue remodelling - COPD: from LABA/ICS to LABA/LAMA/ICS - Cell-matrix interactions in lung disease and regeneration - New predictors of morbidity and mortality in COPD - Respiratory muscles and lung function: from healthy subjects to patients - Granulomatous disorders: epidemiology, genotype and phenotype - Interventional pulmonology highlights in 2018: latest innovations - New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases - Multiomics studies in epidemiology: what can they tell us? - The world of idiopathic pulmonary fibrosis (IPF): global registries - Lung cancer: personalised medicine - New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children - New diagnostic tools for sleep and breathing and healthcare provision options - Respiratory epidemiology: from COPD to factors that associate with lung function and infections - PDW5 Teamability: become an effective team leader and member - Critically ill patients: prognostic factors and biomarkers - Preclinical and clinical studies of critical illness - Muscles and diaphragm, and quality improvement - Non-invasive ventilation for acute respiratory failure - Non-invasive ventilation in chronic respiratory failure - New tools for managing respiratory failure - New methods and concepts in tests of lung and respiratory muscle function - The value of lung function testing in various pathophysiological conditions - Cardiopulmonary exercise testing in COPD and cardiovascular diseases - New methods and concepts in exercise testing - From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS) - Diagnostics including questionnaires - Sleep-disordered breathing: biomarkers and genetics and the role of hypoxia, insomnia, movement disorders and sleep quality - Obesity: comorbidities - Pleural effusions, infections and tumours - Moving lung transplantation forward - Predicting the future: biomarkers of respiratory infection - Pneumonia: from the community to the intensive care unit - Mechanisms of respiratory infection - Improving the quality of life of patients with bronchiectasis - Challenges in tuberculosis care - Tuberculosis comorbidities - Groups who are susceptible to tuberculosis: children, pregnant women and elderly people - Pulmonary tuberculosis: long term complications, rehabilitation and challenges - Lung cancer: new tools for diagnosis and patient assessment - Lung cancer: novel prognostic markers and scores - Lung cancer: modern therapies and beyond - Lung cancer: risk factors, supportive measures and quality improvement - Lung cancer: from the bench to the bedside - Mesothelioma and pleural malignancy: investigations and management - Clinical management of pleural malignancies, including mesothelioma - Consequences of idiopathic interstitial pneumonias - News on the diagnosis of idiopathic interstitial pneumonia - Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF) - CTD-ILD and hypersensitivity pneumonitis:  mechanistic insights and prognostic markers - Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment - Granulomatous disorders: heterogeneous diseases with variable management - Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) - Pulmonary hypertension: therapy - Experimental research in pulmonary hypertension - Clinical aspects of pulmonary hypertension - Pulmonary hypertension in lung diseases and the role of the right ventricle - Diagnosis, prognostication and treatment of pulmonary embolism - Medical education via the web and the internet - COPD, asthma and tuberculosis: benefits related to therapy costs - New biologics for asthma: which patients, which agents, which results, at what cost? - Airway Diseases & Respiratory Infections - Paediatric Respiratory Diseases - ME7 Monitoring of home mechanical ventilation in neuromuscular disorders - PF Occupational lung disease – professional and patient perspectives - ME8 Diagnosing bronchiectasis and cystic fibrosis - ME6 Control of breathing - hypoventilation during sleep, exercise and dyspnoea - ME5 Lung cancer screening - ME14 Bronchiolitis obliterans syndrome in immunodepressed patients - SW9 Cardiopulmonary exercise test interpretation - tips and pitfalls FULLY BOOKED - SW12 Thoracic ultrasound FULLY BOOKED - PDW6 Supporting patients with behaviour change strategies - Chronic pulmonary aspergillosis: from guidelines to real-life implementation - Imaging chronic lung diseases: moving from structure to function  - Idiopathic pulmonary fibrosis diagnosis: new guidelines - Advances in community-acquired pneumonia management  - Roles of innate lymphoid cells in asthma - Microbiomes in respiratory disease - New methods for diagnosing and treating lung diseases - Molecular mechanisms and treatment of pulmonary hypertension - The best of the European Respiratory Journal in 2018 - Pathophysiological aspects of sleep-disordered breathing: intermittent hypoxia - Ventilation and lung imaging in critically ill patients - Lung cancer: new aspects in diagnosis and management - Recent insights in childhood asthma and wheezing - Pulmonary hypertension: right ventricle function, haemodynamics and exercise - Lung transplant science: from primary graft to chronic allograft dysfunction - What’s new in lung function and exercise assessment in COPD? - Exercise is medicine: testing and treating patients with some effort - Cryobiopsy in interstitial lung disease (ILD) - Innovations in equipment and their application - Latest developments in cystic fibrosis - Ensuring impactful independent education - CC6 Interstitial lung diseases  - CC7 Severe asthma - CC8 Non-resolving pneumonia - Pulmonary endoscopy - State of the art session: Respiratory critical care - Proteases: at the cutting edge of lung disease - GINA 2018 and beyond: shaping the future of asthma management - Accelerated ageing in lungs - Prenatal origins of respiratory and atopic disorders - New perspectives on asthma, cough and laryngeal obstruction - Notable Studies in Asthma - Microorganisms and lung ecology: living in peace with bugs - Biomarkers in COPD and asthma - New ideas about respiratory and sleep physiology in children - Acute pulmonary embolism: from diagnosis to treatment - Paediatric respiratory infections: translational and clinical perspectives - Interdependence of COPD and comorbidities and the underlying mechanisms - Muscle adaptations in response to physiotherapeutic interventions in acute and chronic settings - Additional latest insights in pulmonary rehabilitation for chronic lung diseases - CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside - Drug-resistant tuberculosis - Asthma analysis - Novel insights in the basic and translational research on idiopathic interstitial pneumonias - SW19 Clinical interpretation of spirometry results FULLY BOOKED - SW17 Essential skills for the intensive care unit - SW14 Radiological-pathological correlations in different lung diseases for clinicians FULLY BOOKED - Pulmonary endoscopy - Scientific Year in Review - It's my favourite cell that affects your asthma - Recent advances in respiratory disorders with oropharyngeal dysphagia - Fungal infection in the intensive care unit - Recent advances in primary ciliary dyskinesia - Quality, reference values and standards - Progress in rare interstitial lung diseases - New challenges in tackling known diseases with the 10 ERS Principles for Lung Health - Imaging biomarkers and quantitative imaging - Pulmonary embolism: long-term sequelae and advances in therapies  - Novel findings in biomarkers of tobacco use, exposure, hazards and genetics - CTD-ILD and hypersensitivity pneumonitis: risk stratification and management - Telehealth, home rehabilitation and specific adaptations to exercise interventions in different settings - General thoracic surgery - How far are we in terms of predicting mortality and exacerbations in COPD? - Current practices in and attitudes to screening for tuberculosis, and a discussion about genetic diversity - New insights in testing lung and respiratory muscle functions - Asthma and allergy in adults and children and their biomarkers - Pathobiology of pulmonary hypertension - Tests and trends in asthma - Asthma and drugs - Clinical markers of asthma - Patient-reported outcomes and scores in COPD - COPD and extrapulmonary comorbidities - Functional assessment of COPD - Biomarkers of COPD - COPD exacerbations and bronchiectasis - Sarcoidosis, interstitial lung diseases and various clinical problems - Pulmonary rehabilitation: exercise training, body composition, physical activity and other aspects - Aspects of pulmonary rehabilitation and chronic care - Use of stents for tracheal stenosis - Bronchoscopy and transthoracic ultrasound - Primary care management of asthma - Genetics in chronic pulmonary diseases - COPD: immune regulation and therapeutic targets - COPD: novel pathological mechanisms in the airway epithelium - Role of microbial exposure and inflammation in lung injury - Triggers of acute lung injury: mechanical ventilation and oxygen levels - Cardiovascular and metabolic consequences of sleep-disordered breathing - Treatments that can serve as an alternative to positive airway pressure (PAP) - Sleep and breathing control: phenotypes - COPD management - Studies on the mechanisms underlying airway disease - Airway disease: recent discoveries - Clinical and functional monitoring in airway disease - Asthma, rhinitis and COPD: cells, mediators, biomarkers and genetics - Epidemiology of asthma, COPD and factors that associate with lung function - Respiratory epidemiology:  from infectious diseases to lung cancer - Occupational and environmental lung diseases: inhaled air quality and health effects - Epidemiology of the use of traditional and emerging tobacco products and e-cigarettes - Tobacco use, attitudes and cessation training among healthcare professionals and prevention programmes - Improvements in the assessment of paediatric physiology - Paediatric asthma: new insights in its prevalence, treatment and treatment failure - Cystic fibrosis in paediatric patients: current research  - Paediatric respiratory infections: mechanistic insights and clinical outcomes - Neonatology and paediatric intensive care - Insights in primary ciliary dyskinesia, asthma and lung function testing - Clinical challenges in respiratory infection - Difficult-to-treat respiratory infections - The immune response to tuberculosis: development of biomarkers and diagnostic tools - Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis - Diagnosis of tuberculosis - Management of idiopathic interstitial pneumonias: established and new treatments - Back to basics and translational research in idiopathic interstitial pneumonias - Bronchiectasis: new insights in diagnosis and treatment - Sleep and Breathing Disorders - Myths and Truths of Inhaler Technology - Respiratory Infections - ME9 Cryobiopsy in interstitial lung disease FULLY BOOKED - Pulmonary Vascular Diseases & Respiratory Infections - ME11 Management of severe asthma in children - ME10 Pulmonary arterial hypertension: treatment options FULLY BOOKED - ME12 Immunotherapies for lung cancer - ME13 Management of pulmonary and critical care disease during pregnancy - SW20 Clinical interpretation of spirometry results - SW18 Essential skills for the intensive care unit - SW15 Radiological-pathological correlations in different lung diseases for clinicians - Clinical Grand Round  - State of the art session: Interstitial lung diseases - The digital ®evolution in respiratory medicine: a personalised approach? - Pathophysiology of the human lung alveolus - Emerging tobacco products and harm reduction: a tobacco solution to a tobacco problem? - Lung cancer screening and management of solitary pulmonary nodules - Advanced profiling of immune cells in chronic lung diseases - Interventional pulmonology highlights in 2018: ELVR, TLD and BT - Malignant pleural effusions - Chronic thromboembolic pulmonary hypertension - Bronchiectasis: phenotypes, endotypes and new therapies - Early Career Member: career and opportunities - Epidemiology, phenotypes and cardiometabolic comorbidities of obstructive sleep apnoea - Disease exacerbations from a molecular point of view - Cystic fibrosis: diagnosis and monitoring - Understanding the immunopathology that underlies airway obstructive diseases - Primary ciliary dyskinesia and lung function tests in respiratory morbidities - Clinical determinants of asthma and biomarkers - Biomarkers and lung function in airway disease - Occupational and environmental lung diseases: air quality and lung damage - State of the art session: Paediatric respiratory diseases - New trends in the management of pulmonary hypertension - Respiratory medicine meets rheumatology - New drugs, strategies and research designs for advanced non-small cell lung cancer - The complexities of managing mild asthma - Does asthma phenotyping improve treatment? - New determinants of cardiovascular morbidity in COPD - Antimicrobial host defence and innate immunity in the lung - Novel and established imaging studies and findings - Effect of environmental exposure on lung function outcomes - Physiotherapy care for patients with acute and chronic respiratory conditions - Latest advances in pulmonary rehabilitation assessment and content - Sarcoidosis: from basic research to patient outcomes - Innovative tobacco cessation approaches and trends in tobacco and e-cigarette use - What is new in idiopathic interstitial pneumonias? - Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control - Tuberculosis transmission and screening strategies - The importance of the pulmonary function test in different clinical settings - The airway microbiome across the spectrum of airway disease - The asthma-allergy “family”  - Important changes in the management of tuberculosis - Endoscopic solutions for obstructive lung diseases - Palliative care specific for respiratory diseases - Emerging and novel imaging biomarkers in drug-induced interstitial lung disease - Advances in exercise physiopathology - New insights in the signalling pathways that underlie IPF pathophysiology - Effects of smoking on asthma - Progress in basic and translational research on idiopathic interstitial pneumonias - Upper airways morphology and diagnostics, and the challenges associated with mandibular advancement - Lung cancer: novel molecular markers and mechanisms - Eosinophils in airway disease - Endoscopic lung volume reduction See this session or publication
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract Efficacy and safety of bronchoscopic lung volume reduction (BLVR) modalities functioning independent of collateral ventilation in advanced emphysema: Systematic review and meta-analysis
N. Dutt (Jodhpur (Rajasthan), India)
International Congress 2018 - Chinese Programme 2018: Part I - Russian Speaking Programme 2018: Part I - PDW1 Spirometry training programme: become a programme organiser - PG2 Thoracic ultrasound FULLY BOOKED - PG5 Noninvasive ventilation - pitfalls and challenges - PG1 Asthma and chronic obstructive pulmonary disease - PG4 Imaging of the chest - PG7 Sleep-disordered breathing - diagnosis and therapy - PG8 Lung function testing - PG6 Bronchoscopy in pulmonary emergencies - PG9 Chronic obstructive pulmonary disease exacerbations - Primary Care Programme 2018: Part I - PG10 Cystic fibrosis: Basic defects and clinical problems in children  - PG11 Modern approaches in lung cancer diagnostics and therapy - PG3 How to plan for and manage a respiratory epidemic/pandemic - Russian Speaking Programme 2018: Part II - Chinese Programme 2018: Part II - Primary Care Programme 2018: Part II - French Programme 2018: Part I - Spanish and Portuguese Programme 2018: Part I - PG15 Challenging issues in acute interstitial lung diseases - PG12 Interventional pulmonology - PG14 The evolving world of pulmonary rehabilitation - PG16 Advanced cardiopulmonary exercise testing - PG17 Asthma phenotyping - PG13 Challenges in the treatment of tuberculosis - PG18 Cystic fibrosis: management in adult patients - PG19 Heart-lung interaction - French Programme 2018: Part II - Spanish and Portuguese Programme 2018: Part II - CC1 Lung transplantation - CC2 Broad spectrum of chronic thromboembolic pulmonary hypertension - SW1 Body plethysmography - Lung cancer Grand Round - State of the art session: Airways disease - New Sepsis Surviving Campaign guidelines: back to the “art of medicine” - EUREST-PLUS: implementation of the tobacco control policy to reduce lung disease - Difficult paediatric lung disease - ILDs: From bench to bedside - Risk stratification in treatment of pulmonary arterial hypertension - Organoids and pluripotent stem cells  - Respiratory muscles at rest, during exercise and in the critically ill patient - Primary care management of respiratory conditions - Asthma in children and adults: long-term aspects - Prematurity and lung disease - Evolving approaches to differential diagnosis - Epidemiology and prognostication of critically-ill patients - Paediatric asthma: prevention, diagnosis and treatment - The global impact of bronchiectasis and nontuberculous mycobacteria (NTM) - Occupational and environmental lung diseases: asthma and the airways - Evaluation of COPD and various diseases by different imaging modalities - EUS-B and EBUS: optimal utilisation of the EBUS scope - Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities - PDW2 Medical writing - SW5 Endoscopy FULLY BOOKED - SW2 Body plethysmography FULLY BOOKED - Imaging Grand Round - State of the art session: Pulmonary vascular diseases - Cournand lecture: new paradigms in extracorporeal lung assistance - Towards understanding and managing chronic cough - Dyspnoea: a multidimensional and multidisciplinary approach - Imminent global problems in lung cancer require joint action: time for an international alliance! - Mechanisms that underlie exercise limitation in various respiratory diseases - Multidisciplinary approach to ground-glass opacities - Gene-environment interactions in the omics era - Pleural disease: diagnosis, monitoring and management - A fresh view on airway differentiation and regeneration - Cystic fibrosis: microbiological aspects and new treatments - New pharmacological strategies in airway diseases - Challenges in treating tuberculosis and nontuberculous mycobacteria - Clinical news in idiopathic interstitial pneumonias - Assessing pathophysiology in children - COPD phenotypes: a1 antitrypsin deficiency and beyond - Regenerative and anti-fibrotic approaches - Innovative therapies in asthma and COPD - Orphan diseases in children - PDW3 Leading and managing change - Physiological and biological insights in asthma - Asthma: clinical screening tools - Integrated care and non-pharmacological management of COPD - Nutrition and metabolic syndrome in COPD - Cardiovascular morbidities in COPD - COPD around the world - Pharmacological management of COPD - Management of bronchiectasis and large airway diseases - Management of chronic cough and respiratory muscle dysfunction - What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)? - Imaging of various diseases with different imaging modalities - Linear and radial EBUS and peripheral nodules - Pleural interventions - Primary care management of COPD - Functional genomics and COPD: new challenges - Studying novel biomarkers in asthma and COPD - Identification of therapeutic targets for asthma - Pulmonary fibrosis: from models to patients - Pulmonary drug delivery: inhaler use, devices and technologies - New developments in the treatment of asthma - Basic pharmacology - Biomarkers for evaluating COPD - Biomarkers for evaluating asthma - Translational models of the immunopathology that underlies airway obstructive diseases - Role of IgE and interleukin (IL)-5 in Th2-cell signatures - Epidemiology of asthma and allergy: prevalence, incidence and risk factors - Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS) - Occupational and environmental lung diseases: mechanisms, biomarkers and causation - Occupational and environmental lung diseases: influence on the airway and interstitium - Tobacco use and cessation interventions in patients with respiratory, cardiovascular and mental health problems and other populations - Effect of tobacco use on health - Role of omics in population studies - The bad and the ugly in paediatric asthma: comorbidities and exacerbations - Paediatric asthma: new mechanisms and tools - Cystic fibrosis in adults: current research - Clinical problems in paediatric pulmonology - Paediatric bronchology - Molecular and cellular determinants of the developing lung - Respiratory physiology and measurements - Acutely hospitalised patients: physiotherapy interventions and assessment methods - Chronic lung disease : effects of rehabilitation interventions on functional outcomes in patients - Chronic respiratory disease: respiratory muscle function, breathing exercises and airway clearance techniques - Chronic respiratory disease : determinants of physical activity in patients - Chronic respiratory disease: effects of rehabilitation interventions in patients - Contemporary respiratory care: symptoms, the role of the nurse and the organisation of care - Advances in idiopathic pulmonary fibrosis treatment, tracheobronchial reconstruction using bioengineering and clinical prediction rules for diagnosing pulmonary embolism - Interstitial Lung Diseases & Respiratory Infections - ME1 Endoscopic lung volume reduction FULLY BOOKED - ME2 Lung microbiome: study design and standardisation FULLY BOOKED - ME4 Mucus clearance techniques across respiratory care settings - ME3 Bronchoscopic evaluation of recurrent/persistent pneumonia in children - SW6 Endoscopy - SW3 Body plethysmography FULLY BOOKED - PDW4 How to deal with difficult employees and co-workers - Paediatric Year in Review - State of the art session: Sleep and breathing disorders - Current and evolving tests in lung function: pro/con debate - Air pollution and transplantation: near to one's heart and lungs! - Interstitial lung disease: an interdisciplinary approach - Management of pleural infection in 2018 - Best abstracts in pulmonary rehabilitation and chronic care - Cleaning agent exposures: are they really harmful to lung health? - Mitochondrial dysfunction as a driver of lung disease - On the right path: understanding and improving the function of an overloaded right heart ventricle - Educational tools to improve your practice - Novel immunology-based therapies in asthma and COPD - Clinical trials in COPD: new results - New insights in the management of chronic respiratory failure - Variant forms of asthma - Asthma management - Respiratory muscle function, postural control and breathing exercises in chronic respiratory conditions - Systematic reviews on the health effects of emerging tobacco products and electronic nicotine delivery systems (ENDS) - Thoracic surgery, pleural effusions and other general thoracic surgery - Lung cancer: from early diagnosis to modern monitoring strategies - CC3 Lung cancer: personalised treatment and palliative care  - CC4 Tuberculosis - CC5 Pulmonary vasculitis: the great chameleon - SW7 Cardiopulmonary exercise test interpretation - tips and pitfalls FULLY BOOKED - SW10 Thoracic ultrasound FULLY BOOKED - Paediatric Grand Round - State of the art session: Thoracic oncology - Therapeutic breakthroughs Year in Review - New trends in the management of difficult-to-wean patients  - Sleep apnoea: is it time for new therapies? - Rare lung diseases - New modalities in asthma treatment - Pulmonary embolism: what we need to know - Cross-talk in the lung microenvironment: implications for chronic lung disease - COPD and chronic respiratory disease: from misclassification to radiological findings - Novel drug targets for asthma and COPD - Occupational and environmental lung diseases: from early influences and novel exposures to preventative approaches - New developments in tuberculosis - Pleural diseases and pneumonia: what's new ? - Determinants of physical activity behaviour in patients with COPD and the physiotherapist as a physical activity coach  - Integrating pharmacological and non-pharmacological management in COPD: are we there yet? - Clinical determinants and biomarkers of COPD - Improving the outcomes of community-acquired pneumonia - Let’s interact and discuss the hot topics in pulmonary rehabilitation - The many facets of respiratory nursing - SW8 Cardiopulmonary exercise test interpretation - tips and pitfalls FULLY BOOKED - SW11 Thoracic ultrasound FULLY BOOKED - Clinical Year in Review - State of the art session: Respiratory infections - Infectious agents and childhood asthma - Preventing asthma and COPD exacerbations by increasing the inhaled glucocorticoid dose - Integrated care for patients with pulmonary vascular disease, lung diseases and heart failure - Respiratory medicine meets hematology - Intercellular communication in tissue remodelling - COPD: from LABA/ICS to LABA/LAMA/ICS - Cell-matrix interactions in lung disease and regeneration - New predictors of morbidity and mortality in COPD - Respiratory muscles and lung function: from healthy subjects to patients - Granulomatous disorders: epidemiology, genotype and phenotype - Interventional pulmonology highlights in 2018: latest innovations - New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases - Multiomics studies in epidemiology: what can they tell us? - The world of idiopathic pulmonary fibrosis (IPF): global registries - Lung cancer: personalised medicine - New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children - New diagnostic tools for sleep and breathing and healthcare provision options - Respiratory epidemiology: from COPD to factors that associate with lung function and infections - PDW5 Teamability: become an effective team leader and member - Critically ill patients: prognostic factors and biomarkers - Preclinical and clinical studies of critical illness - Muscles and diaphragm, and quality improvement - Non-invasive ventilation for acute respiratory failure - Non-invasive ventilation in chronic respiratory failure - New tools for managing respiratory failure - New methods and concepts in tests of lung and respiratory muscle function - The value of lung function testing in various pathophysiological conditions - Cardiopulmonary exercise testing in COPD and cardiovascular diseases - New methods and concepts in exercise testing - From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS) - Diagnostics including questionnaires - Sleep-disordered breathing: biomarkers and genetics and the role of hypoxia, insomnia, movement disorders and sleep quality - Obesity: comorbidities - Pleural effusions, infections and tumours - Moving lung transplantation forward - Predicting the future: biomarkers of respiratory infection - Pneumonia: from the community to the intensive care unit - Mechanisms of respiratory infection - Improving the quality of life of patients with bronchiectasis - Challenges in tuberculosis care - Tuberculosis comorbidities - Groups who are susceptible to tuberculosis: children, pregnant women and elderly people - Pulmonary tuberculosis: long term complications, rehabilitation and challenges - Lung cancer: new tools for diagnosis and patient assessment - Lung cancer: novel prognostic markers and scores - Lung cancer: modern therapies and beyond - Lung cancer: risk factors, supportive measures and quality improvement - Lung cancer: from the bench to the bedside - Mesothelioma and pleural malignancy: investigations and management - Clinical management of pleural malignancies, including mesothelioma - Consequences of idiopathic interstitial pneumonias - News on the diagnosis of idiopathic interstitial pneumonia - Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF) - CTD-ILD and hypersensitivity pneumonitis:  mechanistic insights and prognostic markers - Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment - Granulomatous disorders: heterogeneous diseases with variable management - Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) - Pulmonary hypertension: therapy - Experimental research in pulmonary hypertension - Clinical aspects of pulmonary hypertension - Pulmonary hypertension in lung diseases and the role of the right ventricle - Diagnosis, prognostication and treatment of pulmonary embolism - Medical education via the web and the internet - COPD, asthma and tuberculosis: benefits related to therapy costs - New biologics for asthma: which patients, which agents, which results, at what cost? - Airway Diseases & Respiratory Infections - Paediatric Respiratory Diseases - ME7 Monitoring of home mechanical ventilation in neuromuscular disorders - PF Occupational lung disease – professional and patient perspectives - ME8 Diagnosing bronchiectasis and cystic fibrosis - ME6 Control of breathing - hypoventilation during sleep, exercise and dyspnoea - ME5 Lung cancer screening - ME14 Bronchiolitis obliterans syndrome in immunodepressed patients - SW9 Cardiopulmonary exercise test interpretation - tips and pitfalls FULLY BOOKED - SW12 Thoracic ultrasound FULLY BOOKED - PDW6 Supporting patients with behaviour change strategies - Chronic pulmonary aspergillosis: from guidelines to real-life implementation - Imaging chronic lung diseases: moving from structure to function  - Idiopathic pulmonary fibrosis diagnosis: new guidelines - Advances in community-acquired pneumonia management  - Roles of innate lymphoid cells in asthma - Microbiomes in respiratory disease - New methods for diagnosing and treating lung diseases - Molecular mechanisms and treatment of pulmonary hypertension - The best of the European Respiratory Journal in 2018 - Pathophysiological aspects of sleep-disordered breathing: intermittent hypoxia - Ventilation and lung imaging in critically ill patients - Lung cancer: new aspects in diagnosis and management - Recent insights in childhood asthma and wheezing - Pulmonary hypertension: right ventricle function, haemodynamics and exercise - Lung transplant science: from primary graft to chronic allograft dysfunction - What’s new in lung function and exercise assessment in COPD? - Exercise is medicine: testing and treating patients with some effort - Cryobiopsy in interstitial lung disease (ILD) - Innovations in equipment and their application - Latest developments in cystic fibrosis - Ensuring impactful independent education - CC6 Interstitial lung diseases  - CC7 Severe asthma - CC8 Non-resolving pneumonia - Pulmonary endoscopy - State of the art session: Respiratory critical care - Proteases: at the cutting edge of lung disease - GINA 2018 and beyond: shaping the future of asthma management - Accelerated ageing in lungs - Prenatal origins of respiratory and atopic disorders - New perspectives on asthma, cough and laryngeal obstruction - Notable Studies in Asthma - Microorganisms and lung ecology: living in peace with bugs - Biomarkers in COPD and asthma - New ideas about respiratory and sleep physiology in children - Acute pulmonary embolism: from diagnosis to treatment - Paediatric respiratory infections: translational and clinical perspectives - Interdependence of COPD and comorbidities and the underlying mechanisms - Muscle adaptations in response to physiotherapeutic interventions in acute and chronic settings - Additional latest insights in pulmonary rehabilitation for chronic lung diseases - CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside - Drug-resistant tuberculosis - Asthma analysis - Novel insights in the basic and translational research on idiopathic interstitial pneumonias - SW19 Clinical interpretation of spirometry results FULLY BOOKED - SW17 Essential skills for the intensive care unit - SW14 Radiological-pathological correlations in different lung diseases for clinicians FULLY BOOKED - Pulmonary endoscopy - Scientific Year in Review - It's my favourite cell that affects your asthma - Recent advances in respiratory disorders with oropharyngeal dysphagia - Fungal infection in the intensive care unit - Recent advances in primary ciliary dyskinesia - Quality, reference values and standards - Progress in rare interstitial lung diseases - New challenges in tackling known diseases with the 10 ERS Principles for Lung Health - Imaging biomarkers and quantitative imaging - Pulmonary embolism: long-term sequelae and advances in therapies  - Novel findings in biomarkers of tobacco use, exposure, hazards and genetics - CTD-ILD and hypersensitivity pneumonitis: risk stratification and management - Telehealth, home rehabilitation and specific adaptations to exercise interventions in different settings - General thoracic surgery - How far are we in terms of predicting mortality and exacerbations in COPD? - Current practices in and attitudes to screening for tuberculosis, and a discussion about genetic diversity - New insights in testing lung and respiratory muscle functions - Asthma and allergy in adults and children and their biomarkers - Pathobiology of pulmonary hypertension - Tests and trends in asthma - Asthma and drugs - Clinical markers of asthma - Patient-reported outcomes and scores in COPD - COPD and extrapulmonary comorbidities - Functional assessment of COPD - Biomarkers of COPD - COPD exacerbations and bronchiectasis - Sarcoidosis, interstitial lung diseases and various clinical problems - Pulmonary rehabilitation: exercise training, body composition, physical activity and other aspects - Aspects of pulmonary rehabilitation and chronic care - Use of stents for tracheal stenosis - Bronchoscopy and transthoracic ultrasound - Primary care management of asthma - Genetics in chronic pulmonary diseases - COPD: immune regulation and therapeutic targets - COPD: novel pathological mechanisms in the airway epithelium - Role of microbial exposure and inflammation in lung injury - Triggers of acute lung injury: mechanical ventilation and oxygen levels - Cardiovascular and metabolic consequences of sleep-disordered breathing - Treatments that can serve as an alternative to positive airway pressure (PAP) - Sleep and breathing control: phenotypes - COPD management - Studies on the mechanisms underlying airway disease - Airway disease: recent discoveries - Clinical and functional monitoring in airway disease - Asthma, rhinitis and COPD: cells, mediators, biomarkers and genetics - Epidemiology of asthma, COPD and factors that associate with lung function - Respiratory epidemiology:  from infectious diseases to lung cancer - Occupational and environmental lung diseases: inhaled air quality and health effects - Epidemiology of the use of traditional and emerging tobacco products and e-cigarettes - Tobacco use, attitudes and cessation training among healthcare professionals and prevention programmes - Improvements in the assessment of paediatric physiology - Paediatric asthma: new insights in its prevalence, treatment and treatment failure - Cystic fibrosis in paediatric patients: current research  - Paediatric respiratory infections: mechanistic insights and clinical outcomes - Neonatology and paediatric intensive care - Insights in primary ciliary dyskinesia, asthma and lung function testing - Clinical challenges in respiratory infection - Difficult-to-treat respiratory infections - The immune response to tuberculosis: development of biomarkers and diagnostic tools - Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis - Diagnosis of tuberculosis - Management of idiopathic interstitial pneumonias: established and new treatments - Back to basics and translational research in idiopathic interstitial pneumonias - Bronchiectasis: new insights in diagnosis and treatment - Sleep and Breathing Disorders - Myths and Truths of Inhaler Technology - Respiratory Infections - ME9 Cryobiopsy in interstitial lung disease FULLY BOOKED - Pulmonary Vascular Diseases & Respiratory Infections - ME11 Management of severe asthma in children - ME10 Pulmonary arterial hypertension: treatment options FULLY BOOKED - ME12 Immunotherapies for lung cancer - ME13 Management of pulmonary and critical care disease during pregnancy - SW20 Clinical interpretation of spirometry results - SW18 Essential skills for the intensive care unit - SW15 Radiological-pathological correlations in different lung diseases for clinicians - Clinical Grand Round  - State of the art session: Interstitial lung diseases - The digital ®evolution in respiratory medicine: a personalised approach? - Pathophysiology of the human lung alveolus - Emerging tobacco products and harm reduction: a tobacco solution to a tobacco problem? - Lung cancer screening and management of solitary pulmonary nodules - Advanced profiling of immune cells in chronic lung diseases - Interventional pulmonology highlights in 2018: ELVR, TLD and BT - Malignant pleural effusions - Chronic thromboembolic pulmonary hypertension - Bronchiectasis: phenotypes, endotypes and new therapies - Early Career Member: career and opportunities - Epidemiology, phenotypes and cardiometabolic comorbidities of obstructive sleep apnoea - Disease exacerbations from a molecular point of view - Cystic fibrosis: diagnosis and monitoring - Understanding the immunopathology that underlies airway obstructive diseases - Primary ciliary dyskinesia and lung function tests in respiratory morbidities - Clinical determinants of asthma and biomarkers - Biomarkers and lung function in airway disease - Occupational and environmental lung diseases: air quality and lung damage - State of the art session: Paediatric respiratory diseases - New trends in the management of pulmonary hypertension - Respiratory medicine meets rheumatology - New drugs, strategies and research designs for advanced non-small cell lung cancer - The complexities of managing mild asthma - Does asthma phenotyping improve treatment? - New determinants of cardiovascular morbidity in COPD - Antimicrobial host defence and innate immunity in the lung - Novel and established imaging studies and findings - Effect of environmental exposure on lung function outcomes - Physiotherapy care for patients with acute and chronic respiratory conditions - Latest advances in pulmonary rehabilitation assessment and content - Sarcoidosis: from basic research to patient outcomes - Innovative tobacco cessation approaches and trends in tobacco and e-cigarette use - What is new in idiopathic interstitial pneumonias? - Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control - Tuberculosis transmission and screening strategies - The importance of the pulmonary function test in different clinical settings - The airway microbiome across the spectrum of airway disease - The asthma-allergy “family”  - Important changes in the management of tuberculosis - Endoscopic solutions for obstructive lung diseases - Palliative care specific for respiratory diseases - Emerging and novel imaging biomarkers in drug-induced interstitial lung disease - Advances in exercise physiopathology - New insights in the signalling pathways that underlie IPF pathophysiology - Effects of smoking on asthma - Progress in basic and translational research on idiopathic interstitial pneumonias - Upper airways morphology and diagnostics, and the challenges associated with mandibular advancement - Lung cancer: novel molecular markers and mechanisms - Eosinophils in airway disease - Endoscopic lung volume reduction See this session or publication
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract Computed Tomography Predictors of Pneumothorax and Hemoptysis after Endobronchial Valve Therapy for Emphysema
D. Oliveira (Porto Alegre (RS), Brazil)
International Congress 2018 - Chinese Programme 2018: Part I - Russian Speaking Programme 2018: Part I - PDW1 Spirometry training programme: become a programme organiser - PG2 Thoracic ultrasound FULLY BOOKED - PG5 Noninvasive ventilation - pitfalls and challenges - PG1 Asthma and chronic obstructive pulmonary disease - PG4 Imaging of the chest - PG7 Sleep-disordered breathing - diagnosis and therapy - PG8 Lung function testing - PG6 Bronchoscopy in pulmonary emergencies - PG9 Chronic obstructive pulmonary disease exacerbations - Primary Care Programme 2018: Part I - PG10 Cystic fibrosis: Basic defects and clinical problems in children  - PG11 Modern approaches in lung cancer diagnostics and therapy - PG3 How to plan for and manage a respiratory epidemic/pandemic - Russian Speaking Programme 2018: Part II - Chinese Programme 2018: Part II - Primary Care Programme 2018: Part II - French Programme 2018: Part I - Spanish and Portuguese Programme 2018: Part I - PG15 Challenging issues in acute interstitial lung diseases - PG12 Interventional pulmonology - PG14 The evolving world of pulmonary rehabilitation - PG16 Advanced cardiopulmonary exercise testing - PG17 Asthma phenotyping - PG13 Challenges in the treatment of tuberculosis - PG18 Cystic fibrosis: management in adult patients - PG19 Heart-lung interaction - French Programme 2018: Part II - Spanish and Portuguese Programme 2018: Part II - CC1 Lung transplantation - CC2 Broad spectrum of chronic thromboembolic pulmonary hypertension - SW1 Body plethysmography - Lung cancer Grand Round - State of the art session: Airways disease - New Sepsis Surviving Campaign guidelines: back to the “art of medicine” - EUREST-PLUS: implementation of the tobacco control policy to reduce lung disease - Difficult paediatric lung disease - ILDs: From bench to bedside - Risk stratification in treatment of pulmonary arterial hypertension - Organoids and pluripotent stem cells  - Respiratory muscles at rest, during exercise and in the critically ill patient - Primary care management of respiratory conditions - Asthma in children and adults: long-term aspects - Prematurity and lung disease - Evolving approaches to differential diagnosis - Epidemiology and prognostication of critically-ill patients - Paediatric asthma: prevention, diagnosis and treatment - The global impact of bronchiectasis and nontuberculous mycobacteria (NTM) - Occupational and environmental lung diseases: asthma and the airways - Evaluation of COPD and various diseases by different imaging modalities - EUS-B and EBUS: optimal utilisation of the EBUS scope - Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities - PDW2 Medical writing - SW5 Endoscopy FULLY BOOKED - SW2 Body plethysmography FULLY BOOKED - Imaging Grand Round - State of the art session: Pulmonary vascular diseases - Cournand lecture: new paradigms in extracorporeal lung assistance - Towards understanding and managing chronic cough - Dyspnoea: a multidimensional and multidisciplinary approach - Imminent global problems in lung cancer require joint action: time for an international alliance! - Mechanisms that underlie exercise limitation in various respiratory diseases - Multidisciplinary approach to ground-glass opacities - Gene-environment interactions in the omics era - Pleural disease: diagnosis, monitoring and management - A fresh view on airway differentiation and regeneration - Cystic fibrosis: microbiological aspects and new treatments - New pharmacological strategies in airway diseases - Challenges in treating tuberculosis and nontuberculous mycobacteria - Clinical news in idiopathic interstitial pneumonias - Assessing pathophysiology in children - COPD phenotypes: a1 antitrypsin deficiency and beyond - Regenerative and anti-fibrotic approaches - Innovative therapies in asthma and COPD - Orphan diseases in children - PDW3 Leading and managing change - Physiological and biological insights in asthma - Asthma: clinical screening tools - Integrated care and non-pharmacological management of COPD - Nutrition and metabolic syndrome in COPD - Cardiovascular morbidities in COPD - COPD around the world - Pharmacological management of COPD - Management of bronchiectasis and large airway diseases - Management of chronic cough and respiratory muscle dysfunction - What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)? - Imaging of various diseases with different imaging modalities - Linear and radial EBUS and peripheral nodules - Pleural interventions - Primary care management of COPD - Functional genomics and COPD: new challenges - Studying novel biomarkers in asthma and COPD - Identification of therapeutic targets for asthma - Pulmonary fibrosis: from models to patients - Pulmonary drug delivery: inhaler use, devices and technologies - New developments in the treatment of asthma - Basic pharmacology - Biomarkers for evaluating COPD - Biomarkers for evaluating asthma - Translational models of the immunopathology that underlies airway obstructive diseases - Role of IgE and interleukin (IL)-5 in Th2-cell signatures - Epidemiology of asthma and allergy: prevalence, incidence and risk factors - Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS) - Occupational and environmental lung diseases: mechanisms, biomarkers and causation - Occupational and environmental lung diseases: influence on the airway and interstitium - Tobacco use and cessation interventions in patients with respiratory, cardiovascular and mental health problems and other populations - Effect of tobacco use on health - Role of omics in population studies - The bad and the ugly in paediatric asthma: comorbidities and exacerbations - Paediatric asthma: new mechanisms and tools - Cystic fibrosis in adults: current research - Clinical problems in paediatric pulmonology - Paediatric bronchology - Molecular and cellular determinants of the developing lung - Respiratory physiology and measurements - Acutely hospitalised patients: physiotherapy interventions and assessment methods - Chronic lung disease : effects of rehabilitation interventions on functional outcomes in patients - Chronic respiratory disease: respiratory muscle function, breathing exercises and airway clearance techniques - Chronic respiratory disease : determinants of physical activity in patients - Chronic respiratory disease: effects of rehabilitation interventions in patients - Contemporary respiratory care: symptoms, the role of the nurse and the organisation of care - Advances in idiopathic pulmonary fibrosis treatment, tracheobronchial reconstruction using bioengineering and clinical prediction rules for diagnosing pulmonary embolism - Interstitial Lung Diseases & Respiratory Infections - ME1 Endoscopic lung volume reduction FULLY BOOKED - ME2 Lung microbiome: study design and standardisation FULLY BOOKED - ME4 Mucus clearance techniques across respiratory care settings - ME3 Bronchoscopic evaluation of recurrent/persistent pneumonia in children - SW6 Endoscopy - SW3 Body plethysmography FULLY BOOKED - PDW4 How to deal with difficult employees and co-workers - Paediatric Year in Review - State of the art session: Sleep and breathing disorders - Current and evolving tests in lung function: pro/con debate - Air pollution and transplantation: near to one's heart and lungs! - Interstitial lung disease: an interdisciplinary approach - Management of pleural infection in 2018 - Best abstracts in pulmonary rehabilitation and chronic care - Cleaning agent exposures: are they really harmful to lung health? - Mitochondrial dysfunction as a driver of lung disease - On the right path: understanding and improving the function of an overloaded right heart ventricle - Educational tools to improve your practice - Novel immunology-based therapies in asthma and COPD - Clinical trials in COPD: new results - New insights in the management of chronic respiratory failure - Variant forms of asthma - Asthma management - Respiratory muscle function, postural control and breathing exercises in chronic respiratory conditions - Systematic reviews on the health effects of emerging tobacco products and electronic nicotine delivery systems (ENDS) - Thoracic surgery, pleural effusions and other general thoracic surgery - Lung cancer: from early diagnosis to modern monitoring strategies - CC3 Lung cancer: personalised treatment and palliative care  - CC4 Tuberculosis - CC5 Pulmonary vasculitis: the great chameleon - SW7 Cardiopulmonary exercise test interpretation - tips and pitfalls FULLY BOOKED - SW10 Thoracic ultrasound FULLY BOOKED - Paediatric Grand Round - State of the art session: Thoracic oncology - Therapeutic breakthroughs Year in Review - New trends in the management of difficult-to-wean patients  - Sleep apnoea: is it time for new therapies? - Rare lung diseases - New modalities in asthma treatment - Pulmonary embolism: what we need to know - Cross-talk in the lung microenvironment: implications for chronic lung disease - COPD and chronic respiratory disease: from misclassification to radiological findings - Novel drug targets for asthma and COPD - Occupational and environmental lung diseases: from early influences and novel exposures to preventative approaches - New developments in tuberculosis - Pleural diseases and pneumonia: what's new ? - Determinants of physical activity behaviour in patients with COPD and the physiotherapist as a physical activity coach  - Integrating pharmacological and non-pharmacological management in COPD: are we there yet? - Clinical determinants and biomarkers of COPD - Improving the outcomes of community-acquired pneumonia - Let’s interact and discuss the hot topics in pulmonary rehabilitation - The many facets of respiratory nursing - SW8 Cardiopulmonary exercise test interpretation - tips and pitfalls FULLY BOOKED - SW11 Thoracic ultrasound FULLY BOOKED - Clinical Year in Review - State of the art session: Respiratory infections - Infectious agents and childhood asthma - Preventing asthma and COPD exacerbations by increasing the inhaled glucocorticoid dose - Integrated care for patients with pulmonary vascular disease, lung diseases and heart failure - Respiratory medicine meets hematology - Intercellular communication in tissue remodelling - COPD: from LABA/ICS to LABA/LAMA/ICS - Cell-matrix interactions in lung disease and regeneration - New predictors of morbidity and mortality in COPD - Respiratory muscles and lung function: from healthy subjects to patients - Granulomatous disorders: epidemiology, genotype and phenotype - Interventional pulmonology highlights in 2018: latest innovations - New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases - Multiomics studies in epidemiology: what can they tell us? - The world of idiopathic pulmonary fibrosis (IPF): global registries - Lung cancer: personalised medicine - New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children - New diagnostic tools for sleep and breathing and healthcare provision options - Respiratory epidemiology: from COPD to factors that associate with lung function and infections - PDW5 Teamability: become an effective team leader and member - Critically ill patients: prognostic factors and biomarkers - Preclinical and clinical studies of critical illness - Muscles and diaphragm, and quality improvement - Non-invasive ventilation for acute respiratory failure - Non-invasive ventilation in chronic respiratory failure - New tools for managing respiratory failure - New methods and concepts in tests of lung and respiratory muscle function - The value of lung function testing in various pathophysiological conditions - Cardiopulmonary exercise testing in COPD and cardiovascular diseases - New methods and concepts in exercise testing - From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS) - Diagnostics including questionnaires - Sleep-disordered breathing: biomarkers and genetics and the role of hypoxia, insomnia, movement disorders and sleep quality - Obesity: comorbidities - Pleural effusions, infections and tumours - Moving lung transplantation forward - Predicting the future: biomarkers of respiratory infection - Pneumonia: from the community to the intensive care unit - Mechanisms of respiratory infection - Improving the quality of life of patients with bronchiectasis - Challenges in tuberculosis care - Tuberculosis comorbidities - Groups who are susceptible to tuberculosis: children, pregnant women and elderly people - Pulmonary tuberculosis: long term complications, rehabilitation and challenges - Lung cancer: new tools for diagnosis and patient assessment - Lung cancer: novel prognostic markers and scores - Lung cancer: modern therapies and beyond - Lung cancer: risk factors, supportive measures and quality improvement - Lung cancer: from the bench to the bedside - Mesothelioma and pleural malignancy: investigations and management - Clinical management of pleural malignancies, including mesothelioma - Consequences of idiopathic interstitial pneumonias - News on the diagnosis of idiopathic interstitial pneumonia - Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF) - CTD-ILD and hypersensitivity pneumonitis:  mechanistic insights and prognostic markers - Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment - Granulomatous disorders: heterogeneous diseases with variable management - Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) - Pulmonary hypertension: therapy - Experimental research in pulmonary hypertension - Clinical aspects of pulmonary hypertension - Pulmonary hypertension in lung diseases and the role of the right ventricle - Diagnosis, prognostication and treatment of pulmonary embolism - Medical education via the web and the internet - COPD, asthma and tuberculosis: benefits related to therapy costs - New biologics for asthma: which patients, which agents, which results, at what cost? - Airway Diseases & Respiratory Infections - Paediatric Respiratory Diseases - ME7 Monitoring of home mechanical ventilation in neuromuscular disorders - PF Occupational lung disease – professional and patient perspectives - ME8 Diagnosing bronchiectasis and cystic fibrosis - ME6 Control of breathing - hypoventilation during sleep, exercise and dyspnoea - ME5 Lung cancer screening - ME14 Bronchiolitis obliterans syndrome in immunodepressed patients - SW9 Cardiopulmonary exercise test interpretation - tips and pitfalls FULLY BOOKED - SW12 Thoracic ultrasound FULLY BOOKED - PDW6 Supporting patients with behaviour change strategies - Chronic pulmonary aspergillosis: from guidelines to real-life implementation - Imaging chronic lung diseases: moving from structure to function  - Idiopathic pulmonary fibrosis diagnosis: new guidelines - Advances in community-acquired pneumonia management  - Roles of innate lymphoid cells in asthma - Microbiomes in respiratory disease - New methods for diagnosing and treating lung diseases - Molecular mechanisms and treatment of pulmonary hypertension - The best of the European Respiratory Journal in 2018 - Pathophysiological aspects of sleep-disordered breathing: intermittent hypoxia - Ventilation and lung imaging in critically ill patients - Lung cancer: new aspects in diagnosis and management - Recent insights in childhood asthma and wheezing - Pulmonary hypertension: right ventricle function, haemodynamics and exercise - Lung transplant science: from primary graft to chronic allograft dysfunction - What’s new in lung function and exercise assessment in COPD? - Exercise is medicine: testing and treating patients with some effort - Cryobiopsy in interstitial lung disease (ILD) - Innovations in equipment and their application - Latest developments in cystic fibrosis - Ensuring impactful independent education - CC6 Interstitial lung diseases  - CC7 Severe asthma - CC8 Non-resolving pneumonia - Pulmonary endoscopy - State of the art session: Respiratory critical care - Proteases: at the cutting edge of lung disease - GINA 2018 and beyond: shaping the future of asthma management - Accelerated ageing in lungs - Prenatal origins of respiratory and atopic disorders - New perspectives on asthma, cough and laryngeal obstruction - Notable Studies in Asthma - Microorganisms and lung ecology: living in peace with bugs - Biomarkers in COPD and asthma - New ideas about respiratory and sleep physiology in children - Acute pulmonary embolism: from diagnosis to treatment - Paediatric respiratory infections: translational and clinical perspectives - Interdependence of COPD and comorbidities and the underlying mechanisms - Muscle adaptations in response to physiotherapeutic interventions in acute and chronic settings - Additional latest insights in pulmonary rehabilitation for chronic lung diseases - CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside - Drug-resistant tuberculosis - Asthma analysis - Novel insights in the basic and translational research on idiopathic interstitial pneumonias - SW19 Clinical interpretation of spirometry results FULLY BOOKED - SW17 Essential skills for the intensive care unit - SW14 Radiological-pathological correlations in different lung diseases for clinicians FULLY BOOKED - Pulmonary endoscopy - Scientific Year in Review - It's my favourite cell that affects your asthma - Recent advances in respiratory disorders with oropharyngeal dysphagia - Fungal infection in the intensive care unit - Recent advances in primary ciliary dyskinesia - Quality, reference values and standards - Progress in rare interstitial lung diseases - New challenges in tackling known diseases with the 10 ERS Principles for Lung Health - Imaging biomarkers and quantitative imaging - Pulmonary embolism: long-term sequelae and advances in therapies  - Novel findings in biomarkers of tobacco use, exposure, hazards and genetics - CTD-ILD and hypersensitivity pneumonitis: risk stratification and management - Telehealth, home rehabilitation and specific adaptations to exercise interventions in different settings - General thoracic surgery - How far are we in terms of predicting mortality and exacerbations in COPD? - Current practices in and attitudes to screening for tuberculosis, and a discussion about genetic diversity - New insights in testing lung and respiratory muscle functions - Asthma and allergy in adults and children and their biomarkers - Pathobiology of pulmonary hypertension - Tests and trends in asthma - Asthma and drugs - Clinical markers of asthma - Patient-reported outcomes and scores in COPD - COPD and extrapulmonary comorbidities - Functional assessment of COPD - Biomarkers of COPD - COPD exacerbations and bronchiectasis - Sarcoidosis, interstitial lung diseases and various clinical problems - Pulmonary rehabilitation: exercise training, body composition, physical activity and other aspects - Aspects of pulmonary rehabilitation and chronic care - Use of stents for tracheal stenosis - Bronchoscopy and transthoracic ultrasound - Primary care management of asthma - Genetics in chronic pulmonary diseases - COPD: immune regulation and therapeutic targets - COPD: novel pathological mechanisms in the airway epithelium - Role of microbial exposure and inflammation in lung injury - Triggers of acute lung injury: mechanical ventilation and oxygen levels - Cardiovascular and metabolic consequences of sleep-disordered breathing - Treatments that can serve as an alternative to positive airway pressure (PAP) - Sleep and breathing control: phenotypes - COPD management - Studies on the mechanisms underlying airway disease - Airway disease: recent discoveries - Clinical and functional monitoring in airway disease - Asthma, rhinitis and COPD: cells, mediators, biomarkers and genetics - Epidemiology of asthma, COPD and factors that associate with lung function - Respiratory epidemiology:  from infectious diseases to lung cancer - Occupational and environmental lung diseases: inhaled air quality and health effects - Epidemiology of the use of traditional and emerging tobacco products and e-cigarettes - Tobacco use, attitudes and cessation training among healthcare professionals and prevention programmes - Improvements in the assessment of paediatric physiology - Paediatric asthma: new insights in its prevalence, treatment and treatment failure - Cystic fibrosis in paediatric patients: current research  - Paediatric respiratory infections: mechanistic insights and clinical outcomes - Neonatology and paediatric intensive care - Insights in primary ciliary dyskinesia, asthma and lung function testing - Clinical challenges in respiratory infection - Difficult-to-treat respiratory infections - The immune response to tuberculosis: development of biomarkers and diagnostic tools - Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis - Diagnosis of tuberculosis - Management of idiopathic interstitial pneumonias: established and new treatments - Back to basics and translational research in idiopathic interstitial pneumonias - Bronchiectasis: new insights in diagnosis and treatment - Sleep and Breathing Disorders - Myths and Truths of Inhaler Technology - Respiratory Infections - ME9 Cryobiopsy in interstitial lung disease FULLY BOOKED - Pulmonary Vascular Diseases & Respiratory Infections - ME11 Management of severe asthma in children - ME10 Pulmonary arterial hypertension: treatment options FULLY BOOKED - ME12 Immunotherapies for lung cancer - ME13 Management of pulmonary and critical care disease during pregnancy - SW20 Clinical interpretation of spirometry results - SW18 Essential skills for the intensive care unit - SW15 Radiological-pathological correlations in different lung diseases for clinicians - Clinical Grand Round  - State of the art session: Interstitial lung diseases - The digital ®evolution in respiratory medicine: a personalised approach? - Pathophysiology of the human lung alveolus - Emerging tobacco products and harm reduction: a tobacco solution to a tobacco problem? - Lung cancer screening and management of solitary pulmonary nodules - Advanced profiling of immune cells in chronic lung diseases - Interventional pulmonology highlights in 2018: ELVR, TLD and BT - Malignant pleural effusions - Chronic thromboembolic pulmonary hypertension - Bronchiectasis: phenotypes, endotypes and new therapies - Early Career Member: career and opportunities - Epidemiology, phenotypes and cardiometabolic comorbidities of obstructive sleep apnoea - Disease exacerbations from a molecular point of view - Cystic fibrosis: diagnosis and monitoring - Understanding the immunopathology that underlies airway obstructive diseases - Primary ciliary dyskinesia and lung function tests in respiratory morbidities - Clinical determinants of asthma and biomarkers - Biomarkers and lung function in airway disease - Occupational and environmental lung diseases: air quality and lung damage - State of the art session: Paediatric respiratory diseases - New trends in the management of pulmonary hypertension - Respiratory medicine meets rheumatology - New drugs, strategies and research designs for advanced non-small cell lung cancer - The complexities of managing mild asthma - Does asthma phenotyping improve treatment? - New determinants of cardiovascular morbidity in COPD - Antimicrobial host defence and innate immunity in the lung - Novel and established imaging studies and findings - Effect of environmental exposure on lung function outcomes - Physiotherapy care for patients with acute and chronic respiratory conditions - Latest advances in pulmonary rehabilitation assessment and content - Sarcoidosis: from basic research to patient outcomes - Innovative tobacco cessation approaches and trends in tobacco and e-cigarette use - What is new in idiopathic interstitial pneumonias? - Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control - Tuberculosis transmission and screening strategies - The importance of the pulmonary function test in different clinical settings - The airway microbiome across the spectrum of airway disease - The asthma-allergy “family”  - Important changes in the management of tuberculosis - Endoscopic solutions for obstructive lung diseases - Palliative care specific for respiratory diseases - Emerging and novel imaging biomarkers in drug-induced interstitial lung disease - Advances in exercise physiopathology - New insights in the signalling pathways that underlie IPF pathophysiology - Effects of smoking on asthma - Progress in basic and translational research on idiopathic interstitial pneumonias - Upper airways morphology and diagnostics, and the challenges associated with mandibular advancement - Lung cancer: novel molecular markers and mechanisms - Eosinophils in airway disease - Endoscopic lung volume reduction See this session or publication
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract Electromagnetic navigation bronchoscopy: parameters associated with a positive result
O. CLAVERIA GARCIA (pamplona, Spain)
International Congress 2018 - Chinese Programme 2018: Part I - Russian Speaking Programme 2018: Part I - PDW1 Spirometry training programme: become a programme organiser - PG2 Thoracic ultrasound FULLY BOOKED - PG5 Noninvasive ventilation - pitfalls and challenges - PG1 Asthma and chronic obstructive pulmonary disease - PG4 Imaging of the chest - PG7 Sleep-disordered breathing - diagnosis and therapy - PG8 Lung function testing - PG6 Bronchoscopy in pulmonary emergencies - PG9 Chronic obstructive pulmonary disease exacerbations - Primary Care Programme 2018: Part I - PG10 Cystic fibrosis: Basic defects and clinical problems in children  - PG11 Modern approaches in lung cancer diagnostics and therapy - PG3 How to plan for and manage a respiratory epidemic/pandemic - Russian Speaking Programme 2018: Part II - Chinese Programme 2018: Part II - Primary Care Programme 2018: Part II - French Programme 2018: Part I - Spanish and Portuguese Programme 2018: Part I - PG15 Challenging issues in acute interstitial lung diseases - PG12 Interventional pulmonology - PG14 The evolving world of pulmonary rehabilitation - PG16 Advanced cardiopulmonary exercise testing - PG17 Asthma phenotyping - PG13 Challenges in the treatment of tuberculosis - PG18 Cystic fibrosis: management in adult patients - PG19 Heart-lung interaction - French Programme 2018: Part II - Spanish and Portuguese Programme 2018: Part II - CC1 Lung transplantation - CC2 Broad spectrum of chronic thromboembolic pulmonary hypertension - SW1 Body plethysmography - Lung cancer Grand Round - State of the art session: Airways disease - New Sepsis Surviving Campaign guidelines: back to the “art of medicine” - EUREST-PLUS: implementation of the tobacco control policy to reduce lung disease - Difficult paediatric lung disease - ILDs: From bench to bedside - Risk stratification in treatment of pulmonary arterial hypertension - Organoids and pluripotent stem cells  - Respiratory muscles at rest, during exercise and in the critically ill patient - Primary care management of respiratory conditions - Asthma in children and adults: long-term aspects - Prematurity and lung disease - Evolving approaches to differential diagnosis - Epidemiology and prognostication of critically-ill patients - Paediatric asthma: prevention, diagnosis and treatment - The global impact of bronchiectasis and nontuberculous mycobacteria (NTM) - Occupational and environmental lung diseases: asthma and the airways - Evaluation of COPD and various diseases by different imaging modalities - EUS-B and EBUS: optimal utilisation of the EBUS scope - Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities - PDW2 Medical writing - SW5 Endoscopy FULLY BOOKED - SW2 Body plethysmography FULLY BOOKED - Imaging Grand Round - State of the art session: Pulmonary vascular diseases - Cournand lecture: new paradigms in extracorporeal lung assistance - Towards understanding and managing chronic cough - Dyspnoea: a multidimensional and multidisciplinary approach - Imminent global problems in lung cancer require joint action: time for an international alliance! - Mechanisms that underlie exercise limitation in various respiratory diseases - Multidisciplinary approach to ground-glass opacities - Gene-environment interactions in the omics era - Pleural disease: diagnosis, monitoring and management - A fresh view on airway differentiation and regeneration - Cystic fibrosis: microbiological aspects and new treatments - New pharmacological strategies in airway diseases - Challenges in treating tuberculosis and nontuberculous mycobacteria - Clinical news in idiopathic interstitial pneumonias - Assessing pathophysiology in children - COPD phenotypes: a1 antitrypsin deficiency and beyond - Regenerative and anti-fibrotic approaches - Innovative therapies in asthma and COPD - Orphan diseases in children - PDW3 Leading and managing change - Physiological and biological insights in asthma - Asthma: clinical screening tools - Integrated care and non-pharmacological management of COPD - Nutrition and metabolic syndrome in COPD - Cardiovascular morbidities in COPD - COPD around the world - Pharmacological management of COPD - Management of bronchiectasis and large airway diseases - Management of chronic cough and respiratory muscle dysfunction - What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)? - Imaging of various diseases with different imaging modalities - Linear and radial EBUS and peripheral nodules - Pleural interventions - Primary care management of COPD - Functional genomics and COPD: new challenges - Studying novel biomarkers in asthma and COPD - Identification of therapeutic targets for asthma - Pulmonary fibrosis: from models to patients - Pulmonary drug delivery: inhaler use, devices and technologies - New developments in the treatment of asthma - Basic pharmacology - Biomarkers for evaluating COPD - Biomarkers for evaluating asthma - Translational models of the immunopathology that underlies airway obstructive diseases - Role of IgE and interleukin (IL)-5 in Th2-cell signatures - Epidemiology of asthma and allergy: prevalence, incidence and risk factors - Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS) - Occupational and environmental lung diseases: mechanisms, biomarkers and causation - Occupational and environmental lung diseases: influence on the airway and interstitium - Tobacco use and cessation interventions in patients with respiratory, cardiovascular and mental health problems and other populations - Effect of tobacco use on health - Role of omics in population studies - The bad and the ugly in paediatric asthma: comorbidities and exacerbations - Paediatric asthma: new mechanisms and tools - Cystic fibrosis in adults: current research - Clinical problems in paediatric pulmonology - Paediatric bronchology - Molecular and cellular determinants of the developing lung - Respiratory physiology and measurements - Acutely hospitalised patients: physiotherapy interventions and assessment methods - Chronic lung disease : effects of rehabilitation interventions on functional outcomes in patients - Chronic respiratory disease: respiratory muscle function, breathing exercises and airway clearance techniques - Chronic respiratory disease : determinants of physical activity in patients - Chronic respiratory disease: effects of rehabilitation interventions in patients - Contemporary respiratory care: symptoms, the role of the nurse and the organisation of care - Advances in idiopathic pulmonary fibrosis treatment, tracheobronchial reconstruction using bioengineering and clinical prediction rules for diagnosing pulmonary embolism - Interstitial Lung Diseases & Respiratory Infections - ME1 Endoscopic lung volume reduction FULLY BOOKED - ME2 Lung microbiome: study design and standardisation FULLY BOOKED - ME4 Mucus clearance techniques across respiratory care settings - ME3 Bronchoscopic evaluation of recurrent/persistent pneumonia in children - SW6 Endoscopy - SW3 Body plethysmography FULLY BOOKED - PDW4 How to deal with difficult employees and co-workers - Paediatric Year in Review - State of the art session: Sleep and breathing disorders - Current and evolving tests in lung function: pro/con debate - Air pollution and transplantation: near to one's heart and lungs! - Interstitial lung disease: an interdisciplinary approach - Management of pleural infection in 2018 - Best abstracts in pulmonary rehabilitation and chronic care - Cleaning agent exposures: are they really harmful to lung health? - Mitochondrial dysfunction as a driver of lung disease - On the right path: understanding and improving the function of an overloaded right heart ventricle - Educational tools to improve your practice - Novel immunology-based therapies in asthma and COPD - Clinical trials in COPD: new results - New insights in the management of chronic respiratory failure - Variant forms of asthma - Asthma management - Respiratory muscle function, postural control and breathing exercises in chronic respiratory conditions - Systematic reviews on the health effects of emerging tobacco products and electronic nicotine delivery systems (ENDS) - Thoracic surgery, pleural effusions and other general thoracic surgery - Lung cancer: from early diagnosis to modern monitoring strategies - CC3 Lung cancer: personalised treatment and palliative care  - CC4 Tuberculosis - CC5 Pulmonary vasculitis: the great chameleon - SW7 Cardiopulmonary exercise test interpretation - tips and pitfalls FULLY BOOKED - SW10 Thoracic ultrasound FULLY BOOKED - Paediatric Grand Round - State of the art session: Thoracic oncology - Therapeutic breakthroughs Year in Review - New trends in the management of difficult-to-wean patients  - Sleep apnoea: is it time for new therapies? - Rare lung diseases - New modalities in asthma treatment - Pulmonary embolism: what we need to know - Cross-talk in the lung microenvironment: implications for chronic lung disease - COPD and chronic respiratory disease: from misclassification to radiological findings - Novel drug targets for asthma and COPD - Occupational and environmental lung diseases: from early influences and novel exposures to preventative approaches - New developments in tuberculosis - Pleural diseases and pneumonia: what's new ? - Determinants of physical activity behaviour in patients with COPD and the physiotherapist as a physical activity coach  - Integrating pharmacological and non-pharmacological management in COPD: are we there yet? - Clinical determinants and biomarkers of COPD - Improving the outcomes of community-acquired pneumonia - Let’s interact and discuss the hot topics in pulmonary rehabilitation - The many facets of respiratory nursing - SW8 Cardiopulmonary exercise test interpretation - tips and pitfalls FULLY BOOKED - SW11 Thoracic ultrasound FULLY BOOKED - Clinical Year in Review - State of the art session: Respiratory infections - Infectious agents and childhood asthma - Preventing asthma and COPD exacerbations by increasing the inhaled glucocorticoid dose - Integrated care for patients with pulmonary vascular disease, lung diseases and heart failure - Respiratory medicine meets hematology - Intercellular communication in tissue remodelling - COPD: from LABA/ICS to LABA/LAMA/ICS - Cell-matrix interactions in lung disease and regeneration - New predictors of morbidity and mortality in COPD - Respiratory muscles and lung function: from healthy subjects to patients - Granulomatous disorders: epidemiology, genotype and phenotype - Interventional pulmonology highlights in 2018: latest innovations - New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases - Multiomics studies in epidemiology: what can they tell us? - The world of idiopathic pulmonary fibrosis (IPF): global registries - Lung cancer: personalised medicine - New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children - New diagnostic tools for sleep and breathing and healthcare provision options - Respiratory epidemiology: from COPD to factors that associate with lung function and infections - PDW5 Teamability: become an effective team leader and member - Critically ill patients: prognostic factors and biomarkers - Preclinical and clinical studies of critical illness - Muscles and diaphragm, and quality improvement - Non-invasive ventilation for acute respiratory failure - Non-invasive ventilation in chronic respiratory failure - New tools for managing respiratory failure - New methods and concepts in tests of lung and respiratory muscle function - The value of lung function testing in various pathophysiological conditions - Cardiopulmonary exercise testing in COPD and cardiovascular diseases - New methods and concepts in exercise testing - From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS) - Diagnostics including questionnaires - Sleep-disordered breathing: biomarkers and genetics and the role of hypoxia, insomnia, movement disorders and sleep quality - Obesity: comorbidities - Pleural effusions, infections and tumours - Moving lung transplantation forward - Predicting the future: biomarkers of respiratory infection - Pneumonia: from the community to the intensive care unit - Mechanisms of respiratory infection - Improving the quality of life of patients with bronchiectasis - Challenges in tuberculosis care - Tuberculosis comorbidities - Groups who are susceptible to tuberculosis: children, pregnant women and elderly people - Pulmonary tuberculosis: long term complications, rehabilitation and challenges - Lung cancer: new tools for diagnosis and patient assessment - Lung cancer: novel prognostic markers and scores - Lung cancer: modern therapies and beyond - Lung cancer: risk factors, supportive measures and quality improvement - Lung cancer: from the bench to the bedside - Mesothelioma and pleural malignancy: investigations and management - Clinical management of pleural malignancies, including mesothelioma - Consequences of idiopathic interstitial pneumonias - News on the diagnosis of idiopathic interstitial pneumonia - Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF) - CTD-ILD and hypersensitivity pneumonitis:  mechanistic insights and prognostic markers - Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment - Granulomatous disorders: heterogeneous diseases with variable management - Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) - Pulmonary hypertension: therapy - Experimental research in pulmonary hypertension - Clinical aspects of pulmonary hypertension - Pulmonary hypertension in lung diseases and the role of the right ventricle - Diagnosis, prognostication and treatment of pulmonary embolism - Medical education via the web and the internet - COPD, asthma and tuberculosis: benefits related to therapy costs - New biologics for asthma: which patients, which agents, which results, at what cost? - Airway Diseases & Respiratory Infections - Paediatric Respiratory Diseases - ME7 Monitoring of home mechanical ventilation in neuromuscular disorders - PF Occupational lung disease – professional and patient perspectives - ME8 Diagnosing bronchiectasis and cystic fibrosis - ME6 Control of breathing - hypoventilation during sleep, exercise and dyspnoea - ME5 Lung cancer screening - ME14 Bronchiolitis obliterans syndrome in immunodepressed patients - SW9 Cardiopulmonary exercise test interpretation - tips and pitfalls FULLY BOOKED - SW12 Thoracic ultrasound FULLY BOOKED - PDW6 Supporting patients with behaviour change strategies - Chronic pulmonary aspergillosis: from guidelines to real-life implementation - Imaging chronic lung diseases: moving from structure to function  - Idiopathic pulmonary fibrosis diagnosis: new guidelines - Advances in community-acquired pneumonia management  - Roles of innate lymphoid cells in asthma - Microbiomes in respiratory disease - New methods for diagnosing and treating lung diseases - Molecular mechanisms and treatment of pulmonary hypertension - The best of the European Respiratory Journal in 2018 - Pathophysiological aspects of sleep-disordered breathing: intermittent hypoxia - Ventilation and lung imaging in critically ill patients - Lung cancer: new aspects in diagnosis and management - Recent insights in childhood asthma and wheezing - Pulmonary hypertension: right ventricle function, haemodynamics and exercise - Lung transplant science: from primary graft to chronic allograft dysfunction - What’s new in lung function and exercise assessment in COPD? - Exercise is medicine: testing and treating patients with some effort - Cryobiopsy in interstitial lung disease (ILD) - Innovations in equipment and their application - Latest developments in cystic fibrosis - Ensuring impactful independent education - CC6 Interstitial lung diseases  - CC7 Severe asthma - CC8 Non-resolving pneumonia - Pulmonary endoscopy - State of the art session: Respiratory critical care - Proteases: at the cutting edge of lung disease - GINA 2018 and beyond: shaping the future of asthma management - Accelerated ageing in lungs - Prenatal origins of respiratory and atopic disorders - New perspectives on asthma, cough and laryngeal obstruction - Notable Studies in Asthma - Microorganisms and lung ecology: living in peace with bugs - Biomarkers in COPD and asthma - New ideas about respiratory and sleep physiology in children - Acute pulmonary embolism: from diagnosis to treatment - Paediatric respiratory infections: translational and clinical perspectives - Interdependence of COPD and comorbidities and the underlying mechanisms - Muscle adaptations in response to physiotherapeutic interventions in acute and chronic settings - Additional latest insights in pulmonary rehabilitation for chronic lung diseases - CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside - Drug-resistant tuberculosis - Asthma analysis - Novel insights in the basic and translational research on idiopathic interstitial pneumonias - SW19 Clinical interpretation of spirometry results FULLY BOOKED - SW17 Essential skills for the intensive care unit - SW14 Radiological-pathological correlations in different lung diseases for clinicians FULLY BOOKED - Pulmonary endoscopy - Scientific Year in Review - It's my favourite cell that affects your asthma - Recent advances in respiratory disorders with oropharyngeal dysphagia - Fungal infection in the intensive care unit - Recent advances in primary ciliary dyskinesia - Quality, reference values and standards - Progress in rare interstitial lung diseases - New challenges in tackling known diseases with the 10 ERS Principles for Lung Health - Imaging biomarkers and quantitative imaging - Pulmonary embolism: long-term sequelae and advances in therapies  - Novel findings in biomarkers of tobacco use, exposure, hazards and genetics - CTD-ILD and hypersensitivity pneumonitis: risk stratification and management - Telehealth, home rehabilitation and specific adaptations to exercise interventions in different settings - General thoracic surgery - How far are we in terms of predicting mortality and exacerbations in COPD? - Current practices in and attitudes to screening for tuberculosis, and a discussion about genetic diversity - New insights in testing lung and respiratory muscle functions - Asthma and allergy in adults and children and their biomarkers - Pathobiology of pulmonary hypertension - Tests and trends in asthma - Asthma and drugs - Clinical markers of asthma - Patient-reported outcomes and scores in COPD - COPD and extrapulmonary comorbidities - Functional assessment of COPD - Biomarkers of COPD - COPD exacerbations and bronchiectasis - Sarcoidosis, interstitial lung diseases and various clinical problems - Pulmonary rehabilitation: exercise training, body composition, physical activity and other aspects - Aspects of pulmonary rehabilitation and chronic care - Use of stents for tracheal stenosis - Bronchoscopy and transthoracic ultrasound - Primary care management of asthma - Genetics in chronic pulmonary diseases - COPD: immune regulation and therapeutic targets - COPD: novel pathological mechanisms in the airway epithelium - Role of microbial exposure and inflammation in lung injury - Triggers of acute lung injury: mechanical ventilation and oxygen levels - Cardiovascular and metabolic consequences of sleep-disordered breathing - Treatments that can serve as an alternative to positive airway pressure (PAP) - Sleep and breathing control: phenotypes - COPD management - Studies on the mechanisms underlying airway disease - Airway disease: recent discoveries - Clinical and functional monitoring in airway disease - Asthma, rhinitis and COPD: cells, mediators, biomarkers and genetics - Epidemiology of asthma, COPD and factors that associate with lung function - Respiratory epidemiology:  from infectious diseases to lung cancer - Occupational and environmental lung diseases: inhaled air quality and health effects - Epidemiology of the use of traditional and emerging tobacco products and e-cigarettes - Tobacco use, attitudes and cessation training among healthcare professionals and prevention programmes - Improvements in the assessment of paediatric physiology - Paediatric asthma: new insights in its prevalence, treatment and treatment failure - Cystic fibrosis in paediatric patients: current research  - Paediatric respiratory infections: mechanistic insights and clinical outcomes - Neonatology and paediatric intensive care - Insights in primary ciliary dyskinesia, asthma and lung function testing - Clinical challenges in respiratory infection - Difficult-to-treat respiratory infections - The immune response to tuberculosis: development of biomarkers and diagnostic tools - Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis - Diagnosis of tuberculosis - Management of idiopathic interstitial pneumonias: established and new treatments - Back to basics and translational research in idiopathic interstitial pneumonias - Bronchiectasis: new insights in diagnosis and treatment - Sleep and Breathing Disorders - Myths and Truths of Inhaler Technology - Respiratory Infections - ME9 Cryobiopsy in interstitial lung disease FULLY BOOKED - Pulmonary Vascular Diseases & Respiratory Infections - ME11 Management of severe asthma in children - ME10 Pulmonary arterial hypertension: treatment options FULLY BOOKED - ME12 Immunotherapies for lung cancer - ME13 Management of pulmonary and critical care disease during pregnancy - SW20 Clinical interpretation of spirometry results - SW18 Essential skills for the intensive care unit - SW15 Radiological-pathological correlations in different lung diseases for clinicians - Clinical Grand Round  - State of the art session: Interstitial lung diseases - The digital ®evolution in respiratory medicine: a personalised approach? - Pathophysiology of the human lung alveolus - Emerging tobacco products and harm reduction: a tobacco solution to a tobacco problem? - Lung cancer screening and management of solitary pulmonary nodules - Advanced profiling of immune cells in chronic lung diseases - Interventional pulmonology highlights in 2018: ELVR, TLD and BT - Malignant pleural effusions - Chronic thromboembolic pulmonary hypertension - Bronchiectasis: phenotypes, endotypes and new therapies - Early Career Member: career and opportunities - Epidemiology, phenotypes and cardiometabolic comorbidities of obstructive sleep apnoea - Disease exacerbations from a molecular point of view - Cystic fibrosis: diagnosis and monitoring - Understanding the immunopathology that underlies airway obstructive diseases - Primary ciliary dyskinesia and lung function tests in respiratory morbidities - Clinical determinants of asthma and biomarkers - Biomarkers and lung function in airway disease - Occupational and environmental lung diseases: air quality and lung damage - State of the art session: Paediatric respiratory diseases - New trends in the management of pulmonary hypertension - Respiratory medicine meets rheumatology - New drugs, strategies and research designs for advanced non-small cell lung cancer - The complexities of managing mild asthma - Does asthma phenotyping improve treatment? - New determinants of cardiovascular morbidity in COPD - Antimicrobial host defence and innate immunity in the lung - Novel and established imaging studies and findings - Effect of environmental exposure on lung function outcomes - Physiotherapy care for patients with acute and chronic respiratory conditions - Latest advances in pulmonary rehabilitation assessment and content - Sarcoidosis: from basic research to patient outcomes - Innovative tobacco cessation approaches and trends in tobacco and e-cigarette use - What is new in idiopathic interstitial pneumonias? - Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control - Tuberculosis transmission and screening strategies - The importance of the pulmonary function test in different clinical settings - The airway microbiome across the spectrum of airway disease - The asthma-allergy “family”  - Important changes in the management of tuberculosis - Endoscopic solutions for obstructive lung diseases - Palliative care specific for respiratory diseases - Emerging and novel imaging biomarkers in drug-induced interstitial lung disease - Advances in exercise physiopathology - New insights in the signalling pathways that underlie IPF pathophysiology - Effects of smoking on asthma - Progress in basic and translational research on idiopathic interstitial pneumonias - Upper airways morphology and diagnostics, and the challenges associated with mandibular advancement - Lung cancer: novel molecular markers and mechanisms - Eosinophils in airway disease - Endoscopic lung volume reduction See this session or publication
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract Relationship between abnormal preoperative spirometry, postoperative mortality and pulmonary complications in non-thoracic surgery
C. Marques (Gondomar, Portugal)
International Congress 2018 - Chinese Programme 2018: Part I - Russian Speaking Programme 2018: Part I - PDW1 Spirometry training programme: become a programme organiser - PG2 Thoracic ultrasound FULLY BOOKED - PG5 Noninvasive ventilation - pitfalls and challenges - PG1 Asthma and chronic obstructive pulmonary disease - PG4 Imaging of the chest - PG7 Sleep-disordered breathing - diagnosis and therapy - PG8 Lung function testing - PG6 Bronchoscopy in pulmonary emergencies - PG9 Chronic obstructive pulmonary disease exacerbations - Primary Care Programme 2018: Part I - PG10 Cystic fibrosis: Basic defects and clinical problems in children  - PG11 Modern approaches in lung cancer diagnostics and therapy - PG3 How to plan for and manage a respiratory epidemic/pandemic - Russian Speaking Programme 2018: Part II - Chinese Programme 2018: Part II - Primary Care Programme 2018: Part II - French Programme 2018: Part I - Spanish and Portuguese Programme 2018: Part I - PG15 Challenging issues in acute interstitial lung diseases - PG12 Interventional pulmonology - PG14 The evolving world of pulmonary rehabilitation - PG16 Advanced cardiopulmonary exercise testing - PG17 Asthma phenotyping - PG13 Challenges in the treatment of tuberculosis - PG18 Cystic fibrosis: management in adult patients - PG19 Heart-lung interaction - French Programme 2018: Part II - Spanish and Portuguese Programme 2018: Part II - CC1 Lung transplantation - CC2 Broad spectrum of chronic thromboembolic pulmonary hypertension - SW1 Body plethysmography - Lung cancer Grand Round - State of the art session: Airways disease - New Sepsis Surviving Campaign guidelines: back to the “art of medicine” - EUREST-PLUS: implementation of the tobacco control policy to reduce lung disease - Difficult paediatric lung disease - ILDs: From bench to bedside - Risk stratification in treatment of pulmonary arterial hypertension - Organoids and pluripotent stem cells  - Respiratory muscles at rest, during exercise and in the critically ill patient - Primary care management of respiratory conditions - Asthma in children and adults: long-term aspects - Prematurity and lung disease - Evolving approaches to differential diagnosis - Epidemiology and prognostication of critically-ill patients - Paediatric asthma: prevention, diagnosis and treatment - The global impact of bronchiectasis and nontuberculous mycobacteria (NTM) - Occupational and environmental lung diseases: asthma and the airways - Evaluation of COPD and various diseases by different imaging modalities - EUS-B and EBUS: optimal utilisation of the EBUS scope - Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities - PDW2 Medical writing - SW5 Endoscopy FULLY BOOKED - SW2 Body plethysmography FULLY BOOKED - Imaging Grand Round - State of the art session: Pulmonary vascular diseases - Cournand lecture: new paradigms in extracorporeal lung assistance - Towards understanding and managing chronic cough - Dyspnoea: a multidimensional and multidisciplinary approach - Imminent global problems in lung cancer require joint action: time for an international alliance! - Mechanisms that underlie exercise limitation in various respiratory diseases - Multidisciplinary approach to ground-glass opacities - Gene-environment interactions in the omics era - Pleural disease: diagnosis, monitoring and management - A fresh view on airway differentiation and regeneration - Cystic fibrosis: microbiological aspects and new treatments - New pharmacological strategies in airway diseases - Challenges in treating tuberculosis and nontuberculous mycobacteria - Clinical news in idiopathic interstitial pneumonias - Assessing pathophysiology in children - COPD phenotypes: a1 antitrypsin deficiency and beyond - Regenerative and anti-fibrotic approaches - Innovative therapies in asthma and COPD - Orphan diseases in children - PDW3 Leading and managing change - Physiological and biological insights in asthma - Asthma: clinical screening tools - Integrated care and non-pharmacological management of COPD - Nutrition and metabolic syndrome in COPD - Cardiovascular morbidities in COPD - COPD around the world - Pharmacological management of COPD - Management of bronchiectasis and large airway diseases - Management of chronic cough and respiratory muscle dysfunction - What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)? - Imaging of various diseases with different imaging modalities - Linear and radial EBUS and peripheral nodules - Pleural interventions - Primary care management of COPD - Functional genomics and COPD: new challenges - Studying novel biomarkers in asthma and COPD - Identification of therapeutic targets for asthma - Pulmonary fibrosis: from models to patients - Pulmonary drug delivery: inhaler use, devices and technologies - New developments in the treatment of asthma - Basic pharmacology - Biomarkers for evaluating COPD - Biomarkers for evaluating asthma - Translational models of the immunopathology that underlies airway obstructive diseases - Role of IgE and interleukin (IL)-5 in Th2-cell signatures - Epidemiology of asthma and allergy: prevalence, incidence and risk factors - Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS) - Occupational and environmental lung diseases: mechanisms, biomarkers and causation - Occupational and environmental lung diseases: influence on the airway and interstitium - Tobacco use and cessation interventions in patients with respiratory, cardiovascular and mental health problems and other populations - Effect of tobacco use on health - Role of omics in population studies - The bad and the ugly in paediatric asthma: comorbidities and exacerbations - Paediatric asthma: new mechanisms and tools - Cystic fibrosis in adults: current research - Clinical problems in paediatric pulmonology - Paediatric bronchology - Molecular and cellular determinants of the developing lung - Respiratory physiology and measurements - Acutely hospitalised patients: physiotherapy interventions and assessment methods - Chronic lung disease : effects of rehabilitation interventions on functional outcomes in patients - Chronic respiratory disease: respiratory muscle function, breathing exercises and airway clearance techniques - Chronic respiratory disease : determinants of physical activity in patients - Chronic respiratory disease: effects of rehabilitation interventions in patients - Contemporary respiratory care: symptoms, the role of the nurse and the organisation of care - Advances in idiopathic pulmonary fibrosis treatment, tracheobronchial reconstruction using bioengineering and clinical prediction rules for diagnosing pulmonary embolism - Interstitial Lung Diseases & Respiratory Infections - ME1 Endoscopic lung volume reduction FULLY BOOKED - ME2 Lung microbiome: study design and standardisation FULLY BOOKED - ME4 Mucus clearance techniques across respiratory care settings - ME3 Bronchoscopic evaluation of recurrent/persistent pneumonia in children - SW6 Endoscopy - SW3 Body plethysmography FULLY BOOKED - PDW4 How to deal with difficult employees and co-workers - Paediatric Year in Review - State of the art session: Sleep and breathing disorders - Current and evolving tests in lung function: pro/con debate - Air pollution and transplantation: near to one's heart and lungs! - Interstitial lung disease: an interdisciplinary approach - Management of pleural infection in 2018 - Best abstracts in pulmonary rehabilitation and chronic care - Cleaning agent exposures: are they really harmful to lung health? - Mitochondrial dysfunction as a driver of lung disease - On the right path: understanding and improving the function of an overloaded right heart ventricle - Educational tools to improve your practice - Novel immunology-based therapies in asthma and COPD - Clinical trials in COPD: new results - New insights in the management of chronic respiratory failure - Variant forms of asthma - Asthma management - Respiratory muscle function, postural control and breathing exercises in chronic respiratory conditions - Systematic reviews on the health effects of emerging tobacco products and electronic nicotine delivery systems (ENDS) - Thoracic surgery, pleural effusions and other general thoracic surgery - Lung cancer: from early diagnosis to modern monitoring strategies - CC3 Lung cancer: personalised treatment and palliative care  - CC4 Tuberculosis - CC5 Pulmonary vasculitis: the great chameleon - SW7 Cardiopulmonary exercise test interpretation - tips and pitfalls FULLY BOOKED - SW10 Thoracic ultrasound FULLY BOOKED - Paediatric Grand Round - State of the art session: Thoracic oncology - Therapeutic breakthroughs Year in Review - New trends in the management of difficult-to-wean patients  - Sleep apnoea: is it time for new therapies? - Rare lung diseases - New modalities in asthma treatment - Pulmonary embolism: what we need to know - Cross-talk in the lung microenvironment: implications for chronic lung disease - COPD and chronic respiratory disease: from misclassification to radiological findings - Novel drug targets for asthma and COPD - Occupational and environmental lung diseases: from early influences and novel exposures to preventative approaches - New developments in tuberculosis - Pleural diseases and pneumonia: what's new ? - Determinants of physical activity behaviour in patients with COPD and the physiotherapist as a physical activity coach  - Integrating pharmacological and non-pharmacological management in COPD: are we there yet? - Clinical determinants and biomarkers of COPD - Improving the outcomes of community-acquired pneumonia - Let’s interact and discuss the hot topics in pulmonary rehabilitation - The many facets of respiratory nursing - SW8 Cardiopulmonary exercise test interpretation - tips and pitfalls FULLY BOOKED - SW11 Thoracic ultrasound FULLY BOOKED - Clinical Year in Review - State of the art session: Respiratory infections - Infectious agents and childhood asthma - Preventing asthma and COPD exacerbations by increasing the inhaled glucocorticoid dose - Integrated care for patients with pulmonary vascular disease, lung diseases and heart failure - Respiratory medicine meets hematology - Intercellular communication in tissue remodelling - COPD: from LABA/ICS to LABA/LAMA/ICS - Cell-matrix interactions in lung disease and regeneration - New predictors of morbidity and mortality in COPD - Respiratory muscles and lung function: from healthy subjects to patients - Granulomatous disorders: epidemiology, genotype and phenotype - Interventional pulmonology highlights in 2018: latest innovations - New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases - Multiomics studies in epidemiology: what can they tell us? - The world of idiopathic pulmonary fibrosis (IPF): global registries - Lung cancer: personalised medicine - New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children - New diagnostic tools for sleep and breathing and healthcare provision options - Respiratory epidemiology: from COPD to factors that associate with lung function and infections - PDW5 Teamability: become an effective team leader and member - Critically ill patients: prognostic factors and biomarkers - Preclinical and clinical studies of critical illness - Muscles and diaphragm, and quality improvement - Non-invasive ventilation for acute respiratory failure - Non-invasive ventilation in chronic respiratory failure - New tools for managing respiratory failure - New methods and concepts in tests of lung and respiratory muscle function - The value of lung function testing in various pathophysiological conditions - Cardiopulmonary exercise testing in COPD and cardiovascular diseases - New methods and concepts in exercise testing - From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS) - Diagnostics including questionnaires - Sleep-disordered breathing: biomarkers and genetics and the role of hypoxia, insomnia, movement disorders and sleep quality - Obesity: comorbidities - Pleural effusions, infections and tumours - Moving lung transplantation forward - Predicting the future: biomarkers of respiratory infection - Pneumonia: from the community to the intensive care unit - Mechanisms of respiratory infection - Improving the quality of life of patients with bronchiectasis - Challenges in tuberculosis care - Tuberculosis comorbidities - Groups who are susceptible to tuberculosis: children, pregnant women and elderly people - Pulmonary tuberculosis: long term complications, rehabilitation and challenges - Lung cancer: new tools for diagnosis and patient assessment - Lung cancer: novel prognostic markers and scores - Lung cancer: modern therapies and beyond - Lung cancer: risk factors, supportive measures and quality improvement - Lung cancer: from the bench to the bedside - Mesothelioma and pleural malignancy: investigations and management - Clinical management of pleural malignancies, including mesothelioma - Consequences of idiopathic interstitial pneumonias - News on the diagnosis of idiopathic interstitial pneumonia - Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF) - CTD-ILD and hypersensitivity pneumonitis:  mechanistic insights and prognostic markers - Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment - Granulomatous disorders: heterogeneous diseases with variable management - Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) - Pulmonary hypertension: therapy - Experimental research in pulmonary hypertension - Clinical aspects of pulmonary hypertension - Pulmonary hypertension in lung diseases and the role of the right ventricle - Diagnosis, prognostication and treatment of pulmonary embolism - Medical education via the web and the internet - COPD, asthma and tuberculosis: benefits related to therapy costs - New biologics for asthma: which patients, which agents, which results, at what cost? - Airway Diseases & Respiratory Infections - Paediatric Respiratory Diseases - ME7 Monitoring of home mechanical ventilation in neuromuscular disorders - PF Occupational lung disease – professional and patient perspectives - ME8 Diagnosing bronchiectasis and cystic fibrosis - ME6 Control of breathing - hypoventilation during sleep, exercise and dyspnoea - ME5 Lung cancer screening - ME14 Bronchiolitis obliterans syndrome in immunodepressed patients - SW9 Cardiopulmonary exercise test interpretation - tips and pitfalls FULLY BOOKED - SW12 Thoracic ultrasound FULLY BOOKED - PDW6 Supporting patients with behaviour change strategies - Chronic pulmonary aspergillosis: from guidelines to real-life implementation - Imaging chronic lung diseases: moving from structure to function  - Idiopathic pulmonary fibrosis diagnosis: new guidelines - Advances in community-acquired pneumonia management  - Roles of innate lymphoid cells in asthma - Microbiomes in respiratory disease - New methods for diagnosing and treating lung diseases - Molecular mechanisms and treatment of pulmonary hypertension - The best of the European Respiratory Journal in 2018 - Pathophysiological aspects of sleep-disordered breathing: intermittent hypoxia - Ventilation and lung imaging in critically ill patients - Lung cancer: new aspects in diagnosis and management - Recent insights in childhood asthma and wheezing - Pulmonary hypertension: right ventricle function, haemodynamics and exercise - Lung transplant science: from primary graft to chronic allograft dysfunction - What’s new in lung function and exercise assessment in COPD? - Exercise is medicine: testing and treating patients with some effort - Cryobiopsy in interstitial lung disease (ILD) - Innovations in equipment and their application - Latest developments in cystic fibrosis - Ensuring impactful independent education - CC6 Interstitial lung diseases  - CC7 Severe asthma - CC8 Non-resolving pneumonia - Pulmonary endoscopy - State of the art session: Respiratory critical care - Proteases: at the cutting edge of lung disease - GINA 2018 and beyond: shaping the future of asthma management - Accelerated ageing in lungs - Prenatal origins of respiratory and atopic disorders - New perspectives on asthma, cough and laryngeal obstruction - Notable Studies in Asthma - Microorganisms and lung ecology: living in peace with bugs - Biomarkers in COPD and asthma - New ideas about respiratory and sleep physiology in children - Acute pulmonary embolism: from diagnosis to treatment - Paediatric respiratory infections: translational and clinical perspectives - Interdependence of COPD and comorbidities and the underlying mechanisms - Muscle adaptations in response to physiotherapeutic interventions in acute and chronic settings - Additional latest insights in pulmonary rehabilitation for chronic lung diseases - CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside - Drug-resistant tuberculosis - Asthma analysis - Novel insights in the basic and translational research on idiopathic interstitial pneumonias - SW19 Clinical interpretation of spirometry results FULLY BOOKED - SW17 Essential skills for the intensive care unit - SW14 Radiological-pathological correlations in different lung diseases for clinicians FULLY BOOKED - Pulmonary endoscopy - Scientific Year in Review - It's my favourite cell that affects your asthma - Recent advances in respiratory disorders with oropharyngeal dysphagia - Fungal infection in the intensive care unit - Recent advances in primary ciliary dyskinesia - Quality, reference values and standards - Progress in rare interstitial lung diseases - New challenges in tackling known diseases with the 10 ERS Principles for Lung Health - Imaging biomarkers and quantitative imaging - Pulmonary embolism: long-term sequelae and advances in therapies  - Novel findings in biomarkers of tobacco use, exposure, hazards and genetics - CTD-ILD and hypersensitivity pneumonitis: risk stratification and management - Telehealth, home rehabilitation and specific adaptations to exercise interventions in different settings - General thoracic surgery - How far are we in terms of predicting mortality and exacerbations in COPD? - Current practices in and attitudes to screening for tuberculosis, and a discussion about genetic diversity - New insights in testing lung and respiratory muscle functions - Asthma and allergy in adults and children and their biomarkers - Pathobiology of pulmonary hypertension - Tests and trends in asthma - Asthma and drugs - Clinical markers of asthma - Patient-reported outcomes and scores in COPD - COPD and extrapulmonary comorbidities - Functional assessment of COPD - Biomarkers of COPD - COPD exacerbations and bronchiectasis - Sarcoidosis, interstitial lung diseases and various clinical problems - Pulmonary rehabilitation: exercise training, body composition, physical activity and other aspects - Aspects of pulmonary rehabilitation and chronic care - Use of stents for tracheal stenosis - Bronchoscopy and transthoracic ultrasound - Primary care management of asthma - Genetics in chronic pulmonary diseases - COPD: immune regulation and therapeutic targets - COPD: novel pathological mechanisms in the airway epithelium - Role of microbial exposure and inflammation in lung injury - Triggers of acute lung injury: mechanical ventilation and oxygen levels - Cardiovascular and metabolic consequences of sleep-disordered breathing - Treatments that can serve as an alternative to positive airway pressure (PAP) - Sleep and breathing control: phenotypes - COPD management - Studies on the mechanisms underlying airway disease - Airway disease: recent discoveries - Clinical and functional monitoring in airway disease - Asthma, rhinitis and COPD: cells, mediators, biomarkers and genetics - Epidemiology of asthma, COPD and factors that associate with lung function - Respiratory epidemiology:  from infectious diseases to lung cancer - Occupational and environmental lung diseases: inhaled air quality and health effects - Epidemiology of the use of traditional and emerging tobacco products and e-cigarettes - Tobacco use, attitudes and cessation training among healthcare professionals and prevention programmes - Improvements in the assessment of paediatric physiology - Paediatric asthma: new insights in its prevalence, treatment and treatment failure - Cystic fibrosis in paediatric patients: current research  - Paediatric respiratory infections: mechanistic insights and clinical outcomes - Neonatology and paediatric intensive care - Insights in primary ciliary dyskinesia, asthma and lung function testing - Clinical challenges in respiratory infection - Difficult-to-treat respiratory infections - The immune response to tuberculosis: development of biomarkers and diagnostic tools - Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis - Diagnosis of tuberculosis - Management of idiopathic interstitial pneumonias: established and new treatments - Back to basics and translational research in idiopathic interstitial pneumonias - Bronchiectasis: new insights in diagnosis and treatment - Sleep and Breathing Disorders - Myths and Truths of Inhaler Technology - Respiratory Infections - ME9 Cryobiopsy in interstitial lung disease FULLY BOOKED - Pulmonary Vascular Diseases & Respiratory Infections - ME11 Management of severe asthma in children - ME10 Pulmonary arterial hypertension: treatment options FULLY BOOKED - ME12 Immunotherapies for lung cancer - ME13 Management of pulmonary and critical care disease during pregnancy - SW20 Clinical interpretation of spirometry results - SW18 Essential skills for the intensive care unit - SW15 Radiological-pathological correlations in different lung diseases for clinicians - Clinical Grand Round  - State of the art session: Interstitial lung diseases - The digital ®evolution in respiratory medicine: a personalised approach? - Pathophysiology of the human lung alveolus - Emerging tobacco products and harm reduction: a tobacco solution to a tobacco problem? - Lung cancer screening and management of solitary pulmonary nodules - Advanced profiling of immune cells in chronic lung diseases - Interventional pulmonology highlights in 2018: ELVR, TLD and BT - Malignant pleural effusions - Chronic thromboembolic pulmonary hypertension - Bronchiectasis: phenotypes, endotypes and new therapies - Early Career Member: career and opportunities - Epidemiology, phenotypes and cardiometabolic comorbidities of obstructive sleep apnoea - Disease exacerbations from a molecular point of view - Cystic fibrosis: diagnosis and monitoring - Understanding the immunopathology that underlies airway obstructive diseases - Primary ciliary dyskinesia and lung function tests in respiratory morbidities - Clinical determinants of asthma and biomarkers - Biomarkers and lung function in airway disease - Occupational and environmental lung diseases: air quality and lung damage - State of the art session: Paediatric respiratory diseases - New trends in the management of pulmonary hypertension - Respiratory medicine meets rheumatology - New drugs, strategies and research designs for advanced non-small cell lung cancer - The complexities of managing mild asthma - Does asthma phenotyping improve treatment? - New determinants of cardiovascular morbidity in COPD - Antimicrobial host defence and innate immunity in the lung - Novel and established imaging studies and findings - Effect of environmental exposure on lung function outcomes - Physiotherapy care for patients with acute and chronic respiratory conditions - Latest advances in pulmonary rehabilitation assessment and content - Sarcoidosis: from basic research to patient outcomes - Innovative tobacco cessation approaches and trends in tobacco and e-cigarette use - What is new in idiopathic interstitial pneumonias? - Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control - Tuberculosis transmission and screening strategies - The importance of the pulmonary function test in different clinical settings See this session or publication
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract Twelve-month positive outcomes of Zephyr endobronchial valves in severe emphysema patients:  LIBERATE trial
D. Slebos (Groningen, Netherlands)
International Congress 2018 - Chinese Programme 2018: Part I - Russian Speaking Programme 2018: Part I - PDW1 Spirometry training programme: become a programme organiser - PG2 Thoracic ultrasound FULLY BOOKED - PG5 Noninvasive ventilation - pitfalls and challenges - PG1 Asthma and chronic obstructive pulmonary disease - PG4 Imaging of the chest - PG7 Sleep-disordered breathing - diagnosis and therapy - PG8 Lung function testing - PG6 Bronchoscopy in pulmonary emergencies - PG9 Chronic obstructive pulmonary disease exacerbations - Primary Care Programme 2018: Part I - PG10 Cystic fibrosis: Basic defects and clinical problems in children  - PG11 Modern approaches in lung cancer diagnostics and therapy - PG3 How to plan for and manage a respiratory epidemic/pandemic - Russian Speaking Programme 2018: Part II - Chinese Programme 2018: Part II - Primary Care Programme 2018: Part II - French Programme 2018: Part I - Spanish and Portuguese Programme 2018: Part I - PG15 Challenging issues in acute interstitial lung diseases - PG12 Interventional pulmonology - PG14 The evolving world of pulmonary rehabilitation - PG16 Advanced cardiopulmonary exercise testing - PG17 Asthma phenotyping - PG13 Challenges in the treatment of tuberculosis - PG18 Cystic fibrosis: management in adult patients - PG19 Heart-lung interaction - French Programme 2018: Part II - Spanish and Portuguese Programme 2018: Part II - CC1 Lung transplantation - CC2 Broad spectrum of chronic thromboembolic pulmonary hypertension - SW1 Body plethysmography - Lung cancer Grand Round - State of the art session: Airways disease - New Sepsis Surviving Campaign guidelines: back to the “art of medicine” - EUREST-PLUS: implementation of the tobacco control policy to reduce lung disease - Difficult paediatric lung disease - ILDs: From bench to bedside - Risk stratification in treatment of pulmonary arterial hypertension - Organoids and pluripotent stem cells  - Respiratory muscles at rest, during exercise and in the critically ill patient - Primary care management of respiratory conditions - Asthma in children and adults: long-term aspects - Prematurity and lung disease - Evolving approaches to differential diagnosis - Epidemiology and prognostication of critically-ill patients - Paediatric asthma: prevention, diagnosis and treatment - The global impact of bronchiectasis and nontuberculous mycobacteria (NTM) - Occupational and environmental lung diseases: asthma and the airways - Evaluation of COPD and various diseases by different imaging modalities - EUS-B and EBUS: optimal utilisation of the EBUS scope - Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities - PDW2 Medical writing - SW5 Endoscopy FULLY BOOKED - SW2 Body plethysmography FULLY BOOKED - Imaging Grand Round - State of the art session: Pulmonary vascular diseases - Cournand lecture: new paradigms in extracorporeal lung assistance - Towards understanding and managing chronic cough - Dyspnoea: a multidimensional and multidisciplinary approach - Imminent global problems in lung cancer require joint action: time for an international alliance! - Mechanisms that underlie exercise limitation in various respiratory diseases - Multidisciplinary approach to ground-glass opacities - Gene-environment interactions in the omics era - Pleural disease: diagnosis, monitoring and management - A fresh view on airway differentiation and regeneration - Cystic fibrosis: microbiological aspects and new treatments - New pharmacological strategies in airway diseases - Challenges in treating tuberculosis and nontuberculous mycobacteria - Clinical news in idiopathic interstitial pneumonias - Assessing pathophysiology in children - COPD phenotypes: a1 antitrypsin deficiency and beyond - Regenerative and anti-fibrotic approaches - Innovative therapies in asthma and COPD - Orphan diseases in children - PDW3 Leading and managing change - Physiological and biological insights in asthma - Asthma: clinical screening tools - Integrated care and non-pharmacological management of COPD - Nutrition and metabolic syndrome in COPD - Cardiovascular morbidities in COPD - COPD around the world - Pharmacological management of COPD - Management of bronchiectasis and large airway diseases - Management of chronic cough and respiratory muscle dysfunction - What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)? - Imaging of various diseases with different imaging modalities - Linear and radial EBUS and peripheral nodules - Pleural interventions - Primary care management of COPD - Functional genomics and COPD: new challenges - Studying novel biomarkers in asthma and COPD - Identification of therapeutic targets for asthma - Pulmonary fibrosis: from models to patients - Pulmonary drug delivery: inhaler use, devices and technologies - New developments in the treatment of asthma - Basic pharmacology - Biomarkers for evaluating COPD - Biomarkers for evaluating asthma - Translational models of the immunopathology that underlies airway obstructive diseases - Role of IgE and interleukin (IL)-5 in Th2-cell signatures - Epidemiology of asthma and allergy: prevalence, incidence and risk factors - Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS) - Occupational and environmental lung diseases: mechanisms, biomarkers and causation - Occupational and environmental lung diseases: influence on the airway and interstitium - Tobacco use and cessation interventions in patients with respiratory, cardiovascular and mental health problems and other populations - Effect of tobacco use on health - Role of omics in population studies - The bad and the ugly in paediatric asthma: comorbidities and exacerbations - Paediatric asthma: new mechanisms and tools - Cystic fibrosis in adults: current research - Clinical problems in paediatric pulmonology - Paediatric bronchology - Molecular and cellular determinants of the developing lung - Respiratory physiology and measurements - Acutely hospitalised patients: physiotherapy interventions and assessment methods - Chronic lung disease : effects of rehabilitation interventions on functional outcomes in patients - Chronic respiratory disease: respiratory muscle function, breathing exercises and airway clearance techniques - Chronic respiratory disease : determinants of physical activity in patients - Chronic respiratory disease: effects of rehabilitation interventions in patients - Contemporary respiratory care: symptoms, the role of the nurse and the organisation of care - Advances in idiopathic pulmonary fibrosis treatment, tracheobronchial reconstruction using bioengineering and clinical prediction rules for diagnosing pulmonary embolism - Interstitial Lung Diseases & Respiratory Infections - ME1 Endoscopic lung volume reduction FULLY BOOKED - ME2 Lung microbiome: study design and standardisation FULLY BOOKED - ME4 Mucus clearance techniques across respiratory care settings - ME3 Bronchoscopic evaluation of recurrent/persistent pneumonia in children - SW6 Endoscopy - SW3 Body plethysmography FULLY BOOKED - PDW4 How to deal with difficult employees and co-workers - Paediatric Year in Review - State of the art session: Sleep and breathing disorders - Current and evolving tests in lung function: pro/con debate - Air pollution and transplantation: near to one's heart and lungs! - Interstitial lung disease: an interdisciplinary approach - Management of pleural infection in 2018 - Best abstracts in pulmonary rehabilitation and chronic care - Cleaning agent exposures: are they really harmful to lung health? - Mitochondrial dysfunction as a driver of lung disease - On the right path: understanding and improving the function of an overloaded right heart ventricle - Educational tools to improve your practice - Novel immunology-based therapies in asthma and COPD - Clinical trials in COPD: new results - New insights in the management of chronic respiratory failure - Variant forms of asthma - Asthma management - Respiratory muscle function, postural control and breathing exercises in chronic respiratory conditions - Systematic reviews on the health effects of emerging tobacco products and electronic nicotine delivery systems (ENDS) - Thoracic surgery, pleural effusions and other general thoracic surgery - Lung cancer: from early diagnosis to modern monitoring strategies - CC3 Lung cancer: personalised treatment and palliative care  - CC4 Tuberculosis - CC5 Pulmonary vasculitis: the great chameleon - SW7 Cardiopulmonary exercise test interpretation - tips and pitfalls FULLY BOOKED - SW10 Thoracic ultrasound FULLY BOOKED - Paediatric Grand Round - State of the art session: Thoracic oncology - Therapeutic breakthroughs Year in Review - New trends in the management of difficult-to-wean patients  - Sleep apnoea: is it time for new therapies? - Rare lung diseases - New modalities in asthma treatment - Pulmonary embolism: what we need to know - Cross-talk in the lung microenvironment: implications for chronic lung disease - COPD and chronic respiratory disease: from misclassification to radiological findings - Novel drug targets for asthma and COPD - Occupational and environmental lung diseases: from early influences and novel exposures to preventative approaches - New developments in tuberculosis - Pleural diseases and pneumonia: what's new ? - Determinants of physical activity behaviour in patients with COPD and the physiotherapist as a physical activity coach  - Integrating pharmacological and non-pharmacological management in COPD: are we there yet? - Clinical determinants and biomarkers of COPD - Improving the outcomes of community-acquired pneumonia - Let’s interact and discuss the hot topics in pulmonary rehabilitation - The many facets of respiratory nursing - SW8 Cardiopulmonary exercise test interpretation - tips and pitfalls FULLY BOOKED - SW11 Thoracic ultrasound FULLY BOOKED - Clinical Year in Review - State of the art session: Respiratory infections - Infectious agents and childhood asthma - Preventing asthma and COPD exacerbations by increasing the inhaled glucocorticoid dose - Integrated care for patients with pulmonary vascular disease, lung diseases and heart failure - Respiratory medicine meets hematology - Intercellular communication in tissue remodelling - COPD: from LABA/ICS to LABA/LAMA/ICS - Cell-matrix interactions in lung disease and regeneration - New predictors of morbidity and mortality in COPD - Respiratory muscles and lung function: from healthy subjects to patients - Granulomatous disorders: epidemiology, genotype and phenotype - Interventional pulmonology highlights in 2018: latest innovations - New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases - Multiomics studies in epidemiology: what can they tell us? - The world of idiopathic pulmonary fibrosis (IPF): global registries - Lung cancer: personalised medicine - New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children - New diagnostic tools for sleep and breathing and healthcare provision options - Respiratory epidemiology: from COPD to factors that associate with lung function and infections - PDW5 Teamability: become an effective team leader and member - Critically ill patients: prognostic factors and biomarkers - Preclinical and clinical studies of critical illness - Muscles and diaphragm, and quality improvement - Non-invasive ventilation for acute respiratory failure - Non-invasive ventilation in chronic respiratory failure - New tools for managing respiratory failure - New methods and concepts in tests of lung and respiratory muscle function - The value of lung function testing in various pathophysiological conditions - Cardiopulmonary exercise testing in COPD and cardiovascular diseases - New methods and concepts in exercise testing - From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS) - Diagnostics including questionnaires - Sleep-disordered breathing: biomarkers and genetics and the role of hypoxia, insomnia, movement disorders and sleep quality - Obesity: comorbidities - Pleural effusions, infections and tumours - Moving lung transplantation forward - Predicting the future: biomarkers of respiratory infection - Pneumonia: from the community to the intensive care unit - Mechanisms of respiratory infection - Improving the quality of life of patients with bronchiectasis - Challenges in tuberculosis care - Tuberculosis comorbidities - Groups who are susceptible to tuberculosis: children, pregnant women and elderly people - Pulmonary tuberculosis: long term complications, rehabilitation and challenges - Lung cancer: new tools for diagnosis and patient assessment - Lung cancer: novel prognostic markers and scores - Lung cancer: modern therapies and beyond - Lung cancer: risk factors, supportive measures and quality improvement - Lung cancer: from the bench to the bedside - Mesothelioma and pleural malignancy: investigations and management - Clinical management of pleural malignancies, including mesothelioma - Consequences of idiopathic interstitial pneumonias - News on the diagnosis of idiopathic interstitial pneumonia - Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF) - CTD-ILD and hypersensitivity pneumonitis:  mechanistic insights and prognostic markers - Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment - Granulomatous disorders: heterogeneous diseases with variable management - Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) - Pulmonary hypertension: therapy - Experimental research in pulmonary hypertension - Clinical aspects of pulmonary hypertension - Pulmonary hypertension in lung diseases and the role of the right ventricle - Diagnosis, prognostication and treatment of pulmonary embolism - Medical education via the web and the internet - COPD, asthma and tuberculosis: benefits related to therapy costs - New biologics for asthma: which patients, which agents, which results, at what cost? - Airway Diseases & Respiratory Infections - Paediatric Respiratory Diseases - ME7 Monitoring of home mechanical ventilation in neuromuscular disorders - PF Occupational lung disease – professional and patient perspectives - ME8 Diagnosing bronchiectasis and cystic fibrosis - ME6 Control of breathing - hypoventilation during sleep, exercise and dyspnoea - ME5 Lung cancer screening - ME14 Bronchiolitis obliterans syndrome in immunodepressed patients - SW9 Cardiopulmonary exercise test interpretation - tips and pitfalls FULLY BOOKED - SW12 Thoracic ultrasound FULLY BOOKED - PDW6 Supporting patients with behaviour change strategies - Chronic pulmonary aspergillosis: from guidelines to real-life implementation - Imaging chronic lung diseases: moving from structure to function  - Idiopathic pulmonary fibrosis diagnosis: new guidelines - Advances in community-acquired pneumonia management  - Roles of innate lymphoid cells in asthma - Microbiomes in respiratory disease - New methods for diagnosing and treating lung diseases - Molecular mechanisms and treatment of pulmonary hypertension - The best of the European Respiratory Journal in 2018 - Pathophysiological aspects of sleep-disordered breathing: intermittent hypoxia - Ventilation and lung imaging in critically ill patients - Lung cancer: new aspects in diagnosis and management - Recent insights in childhood asthma and wheezing - Pulmonary hypertension: right ventricle function, haemodynamics and exercise - Lung transplant science: from primary graft to chronic allograft dysfunction - What’s new in lung function and exercise assessment in COPD? - Exercise is medicine: testing and treating patients with some effort - Cryobiopsy in interstitial lung disease (ILD) - Innovations in equipment and their application - Latest developments in cystic fibrosis - Ensuring impactful independent education - CC6 Interstitial lung diseases  - CC7 Severe asthma - CC8 Non-resolving pneumonia - Pulmonary endoscopy - State of the art session: Respiratory critical care - Proteases: at the cutting edge of lung disease - GINA 2018 and beyond: shaping the future of asthma management - Accelerated ageing in lungs - Prenatal origins of respiratory and atopic disorders - New perspectives on asthma, cough and laryngeal obstruction - Notable Studies in Asthma - Microorganisms and lung ecology: living in peace with bugs - Biomarkers in COPD and asthma - New ideas about respiratory and sleep physiology in children - Acute pulmonary embolism: from diagnosis to treatment - Paediatric respiratory infections: translational and clinical perspectives - Interdependence of COPD and comorbidities and the underlying mechanisms - Muscle adaptations in response to physiotherapeutic interventions in acute and chronic settings - Additional latest insights in pulmonary rehabilitation for chronic lung diseases - CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside - Drug-resistant tuberculosis - Asthma analysis - Novel insights in the basic and translational research on idiopathic interstitial pneumonias - SW19 Clinical interpretation of spirometry results FULLY BOOKED - SW17 Essential skills for the intensive care unit - SW14 Radiological-pathological correlations in different lung diseases for clinicians FULLY BOOKED - Pulmonary endoscopy - Scientific Year in Review - It's my favourite cell that affects your asthma - Recent advances in respiratory disorders with oropharyngeal dysphagia - Fungal infection in the intensive care unit - Recent advances in primary ciliary dyskinesia - Quality, reference values and standards - Progress in rare interstitial lung diseases - New challenges in tackling known diseases with the 10 ERS Principles for Lung Health - Imaging biomarkers and quantitative imaging - Pulmonary embolism: long-term sequelae and advances in therapies  - Novel findings in biomarkers of tobacco use, exposure, hazards and genetics - CTD-ILD and hypersensitivity pneumonitis: risk stratification and management - Telehealth, home rehabilitation and specific adaptations to exercise interventions in different settings - General thoracic surgery - How far are we in terms of predicting mortality and exacerbations in COPD? - Current practices in and attitudes to screening for tuberculosis, and a discussion about genetic diversity - New insights in testing lung and respiratory muscle functions - Asthma and allergy in adults and children and their biomarkers - Pathobiology of pulmonary hypertension - Tests and trends in asthma - Asthma and drugs - Clinical markers of asthma - Patient-reported outcomes and scores in COPD - COPD and extrapulmonary comorbidities - Functional assessment of COPD - Biomarkers of COPD - COPD exacerbations and bronchiectasis - Sarcoidosis, interstitial lung diseases and various clinical problems - Pulmonary rehabilitation: exercise training, body composition, physical activity and other aspects - Aspects of pulmonary rehabilitation and chronic care - Use of stents for tracheal stenosis - Bronchoscopy and transthoracic ultrasound - Primary care management of asthma - Genetics in chronic pulmonary diseases - COPD: immune regulation and therapeutic targets - COPD: novel pathological mechanisms in the airway epithelium - Role of microbial exposure and inflammation in lung injury - Triggers of acute lung injury: mechanical ventilation and oxygen levels - Cardiovascular and metabolic consequences of sleep-disordered breathing - Treatments that can serve as an alternative to positive airway pressure (PAP) - Sleep and breathing control: phenotypes - COPD management - Studies on the mechanisms underlying airway disease - Airway disease: recent discoveries - Clinical and functional monitoring in airway disease - Asthma, rhinitis and COPD: cells, mediators, biomarkers and genetics - Epidemiology of asthma, COPD and factors that associate with lung function - Respiratory epidemiology:  from infectious diseases to lung cancer - Occupational and environmental lung diseases: inhaled air quality and health effects - Epidemiology of the use of traditional and emerging tobacco products and e-cigarettes - Tobacco use, attitudes and cessation training among healthcare professionals and prevention programmes - Improvements in the assessment of paediatric physiology - Paediatric asthma: new insights in its prevalence, treatment and treatment failure - Cystic fibrosis in paediatric patients: current research  - Paediatric respiratory infections: mechanistic insights and clinical outcomes - Neonatology and paediatric intensive care - Insights in primary ciliary dyskinesia, asthma and lung function testing - Clinical challenges in respiratory infection - Difficult-to-treat respiratory infections - The immune response to tuberculosis: development of biomarkers and diagnostic tools - Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis - Diagnosis of tuberculosis - Management of idiopathic interstitial pneumonias: established and new treatments - Back to basics and translational research in idiopathic interstitial pneumonias - Bronchiectasis: new insights in diagnosis and treatment - Sleep and Breathing Disorders - Myths and Truths of Inhaler Technology - Respiratory Infections - ME9 Cryobiopsy in interstitial lung disease FULLY BOOKED - Pulmonary Vascular Diseases & Respiratory Infections - ME11 Management of severe asthma in children - ME10 Pulmonary arterial hypertension: treatment options FULLY BOOKED - ME12 Immunotherapies for lung cancer - ME13 Management of pulmonary and critical care disease during pregnancy - SW20 Clinical interpretation of spirometry results - SW18 Essential skills for the intensive care unit - SW15 Radiological-pathological correlations in different lung diseases for clinicians - Clinical Grand Round  - State of the art session: Interstitial lung diseases - The digital ®evolution in respiratory medicine: a personalised approach? - Pathophysiology of the human lung alveolus - Emerging tobacco products and harm reduction: a tobacco solution to a tobacco problem? - Lung cancer screening and management of solitary pulmonary nodules - Advanced profiling of immune cells in chronic lung diseases - Interventional pulmonology highlights in 2018: ELVR, TLD and BT See this session or publication
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract Late Breaking Abstract - Endobronchial Valves for Severe Emphysema – 12-month Results of the EMPROVE Trial
G. Criner (Philadelphia, United States of America)
International Congress 2018 - Chinese Programme 2018: Part I - Russian Speaking Programme 2018: Part I - PDW1 Spirometry training programme: become a programme organiser - PG2 Thoracic ultrasound FULLY BOOKED - PG5 Noninvasive ventilation - pitfalls and challenges - PG1 Asthma and chronic obstructive pulmonary disease - PG4 Imaging of the chest - PG7 Sleep-disordered breathing - diagnosis and therapy - PG8 Lung function testing - PG6 Bronchoscopy in pulmonary emergencies - PG9 Chronic obstructive pulmonary disease exacerbations - Primary Care Programme 2018: Part I - PG10 Cystic fibrosis: Basic defects and clinical problems in children  - PG11 Modern approaches in lung cancer diagnostics and therapy - PG3 How to plan for and manage a respiratory epidemic/pandemic - Russian Speaking Programme 2018: Part II - Chinese Programme 2018: Part II - Primary Care Programme 2018: Part II - French Programme 2018: Part I - Spanish and Portuguese Programme 2018: Part I - PG15 Challenging issues in acute interstitial lung diseases - PG12 Interventional pulmonology - PG14 The evolving world of pulmonary rehabilitation - PG16 Advanced cardiopulmonary exercise testing - PG17 Asthma phenotyping - PG13 Challenges in the treatment of tuberculosis - PG18 Cystic fibrosis: management in adult patients - PG19 Heart-lung interaction - French Programme 2018: Part II - Spanish and Portuguese Programme 2018: Part II - CC1 Lung transplantation - CC2 Broad spectrum of chronic thromboembolic pulmonary hypertension - SW1 Body plethysmography - Lung cancer Grand Round - State of the art session: Airways disease - New Sepsis Surviving Campaign guidelines: back to the “art of medicine” - EUREST-PLUS: implementation of the tobacco control policy to reduce lung disease - Difficult paediatric lung disease - ILDs: From bench to bedside - Risk stratification in treatment of pulmonary arterial hypertension - Organoids and pluripotent stem cells  - Respiratory muscles at rest, during exercise and in the critically ill patient - Primary care management of respiratory conditions - Asthma in children and adults: long-term aspects - Prematurity and lung disease - Evolving approaches to differential diagnosis - Epidemiology and prognostication of critically-ill patients - Paediatric asthma: prevention, diagnosis and treatment - The global impact of bronchiectasis and nontuberculous mycobacteria (NTM) - Occupational and environmental lung diseases: asthma and the airways - Evaluation of COPD and various diseases by different imaging modalities - EUS-B and EBUS: optimal utilisation of the EBUS scope - Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities - PDW2 Medical writing - SW5 Endoscopy FULLY BOOKED - SW2 Body plethysmography FULLY BOOKED - Imaging Grand Round - State of the art session: Pulmonary vascular diseases - Cournand lecture: new paradigms in extracorporeal lung assistance - Towards understanding and managing chronic cough - Dyspnoea: a multidimensional and multidisciplinary approach - Imminent global problems in lung cancer require joint action: time for an international alliance! - Mechanisms that underlie exercise limitation in various respiratory diseases - Multidisciplinary approach to ground-glass opacities - Gene-environment interactions in the omics era - Pleural disease: diagnosis, monitoring and management - A fresh view on airway differentiation and regeneration - Cystic fibrosis: microbiological aspects and new treatments - New pharmacological strategies in airway diseases - Challenges in treating tuberculosis and nontuberculous mycobacteria - Clinical news in idiopathic interstitial pneumonias - Assessing pathophysiology in children - COPD phenotypes: a1 antitrypsin deficiency and beyond - Regenerative and anti-fibrotic approaches - Innovative therapies in asthma and COPD - Orphan diseases in children - PDW3 Leading and managing change - Physiological and biological insights in asthma - Asthma: clinical screening tools - Integrated care and non-pharmacological management of COPD - Nutrition and metabolic syndrome in COPD - Cardiovascular morbidities in COPD - COPD around the world - Pharmacological management of COPD - Management of bronchiectasis and large airway diseases - Management of chronic cough and respiratory muscle dysfunction - What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)? - Imaging of various diseases with different imaging modalities - Linear and radial EBUS and peripheral nodules - Pleural interventions - Primary care management of COPD - Functional genomics and COPD: new challenges - Studying novel biomarkers in asthma and COPD - Identification of therapeutic targets for asthma - Pulmonary fibrosis: from models to patients - Pulmonary drug delivery: inhaler use, devices and technologies - New developments in the treatment of asthma - Basic pharmacology - Biomarkers for evaluating COPD - Biomarkers for evaluating asthma - Translational models of the immunopathology that underlies airway obstructive diseases - Role of IgE and interleukin (IL)-5 in Th2-cell signatures - Epidemiology of asthma and allergy: prevalence, incidence and risk factors - Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS) - Occupational and environmental lung diseases: mechanisms, biomarkers and causation - Occupational and environmental lung diseases: influence on the airway and interstitium - Tobacco use and cessation interventions in patients with respiratory, cardiovascular and mental health problems and other populations - Effect of tobacco use on health - Role of omics in population studies - The bad and the ugly in paediatric asthma: comorbidities and exacerbations - Paediatric asthma: new mechanisms and tools - Cystic fibrosis in adults: current research - Clinical problems in paediatric pulmonology - Paediatric bronchology - Molecular and cellular determinants of the developing lung - Respiratory physiology and measurements - Acutely hospitalised patients: physiotherapy interventions and assessment methods - Chronic lung disease : effects of rehabilitation interventions on functional outcomes in patients - Chronic respiratory disease: respiratory muscle function, breathing exercises and airway clearance techniques - Chronic respiratory disease : determinants of physical activity in patients - Chronic respiratory disease: effects of rehabilitation interventions in patients - Contemporary respiratory care: symptoms, the role of the nurse and the organisation of care - Advances in idiopathic pulmonary fibrosis treatment, tracheobronchial reconstruction using bioengineering and clinical prediction rules for diagnosing pulmonary embolism - Interstitial Lung Diseases & Respiratory Infections - ME1 Endoscopic lung volume reduction FULLY BOOKED - ME2 Lung microbiome: study design and standardisation FULLY BOOKED - ME4 Mucus clearance techniques across respiratory care settings - ME3 Bronchoscopic evaluation of recurrent/persistent pneumonia in children - SW6 Endoscopy - SW3 Body plethysmography FULLY BOOKED - PDW4 How to deal with difficult employees and co-workers - Paediatric Year in Review - State of the art session: Sleep and breathing disorders - Current and evolving tests in lung function: pro/con debate - Air pollution and transplantation: near to one's heart and lungs! - Interstitial lung disease: an interdisciplinary approach - Management of pleural infection in 2018 - Best abstracts in pulmonary rehabilitation and chronic care - Cleaning agent exposures: are they really harmful to lung health? - Mitochondrial dysfunction as a driver of lung disease - On the right path: understanding and improving the function of an overloaded right heart ventricle - Educational tools to improve your practice - Novel immunology-based therapies in asthma and COPD - Clinical trials in COPD: new results - New insights in the management of chronic respiratory failure - Variant forms of asthma - Asthma management - Respiratory muscle function, postural control and breathing exercises in chronic respiratory conditions - Systematic reviews on the health effects of emerging tobacco products and electronic nicotine delivery systems (ENDS) - Thoracic surgery, pleural effusions and other general thoracic surgery - Lung cancer: from early diagnosis to modern monitoring strategies - CC3 Lung cancer: personalised treatment and palliative care  - CC4 Tuberculosis - CC5 Pulmonary vasculitis: the great chameleon - SW7 Cardiopulmonary exercise test interpretation - tips and pitfalls FULLY BOOKED - SW10 Thoracic ultrasound FULLY BOOKED - Paediatric Grand Round - State of the art session: Thoracic oncology - Therapeutic breakthroughs Year in Review - New trends in the management of difficult-to-wean patients  - Sleep apnoea: is it time for new therapies? - Rare lung diseases - New modalities in asthma treatment - Pulmonary embolism: what we need to know - Cross-talk in the lung microenvironment: implications for chronic lung disease - COPD and chronic respiratory disease: from misclassification to radiological findings - Novel drug targets for asthma and COPD - Occupational and environmental lung diseases: from early influences and novel exposures to preventative approaches - New developments in tuberculosis - Pleural diseases and pneumonia: what's new ? - Determinants of physical activity behaviour in patients with COPD and the physiotherapist as a physical activity coach  - Integrating pharmacological and non-pharmacological management in COPD: are we there yet? - Clinical determinants and biomarkers of COPD - Improving the outcomes of community-acquired pneumonia - Let’s interact and discuss the hot topics in pulmonary rehabilitation - The many facets of respiratory nursing - SW8 Cardiopulmonary exercise test interpretation - tips and pitfalls FULLY BOOKED - SW11 Thoracic ultrasound FULLY BOOKED - Clinical Year in Review - State of the art session: Respiratory infections - Infectious agents and childhood asthma - Preventing asthma and COPD exacerbations by increasing the inhaled glucocorticoid dose - Integrated care for patients with pulmonary vascular disease, lung diseases and heart failure - Respiratory medicine meets hematology - Intercellular communication in tissue remodelling - COPD: from LABA/ICS to LABA/LAMA/ICS - Cell-matrix interactions in lung disease and regeneration - New predictors of morbidity and mortality in COPD - Respiratory muscles and lung function: from healthy subjects to patients - Granulomatous disorders: epidemiology, genotype and phenotype - Interventional pulmonology highlights in 2018: latest innovations - New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases - Multiomics studies in epidemiology: what can they tell us? - The world of idiopathic pulmonary fibrosis (IPF): global registries - Lung cancer: personalised medicine - New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children - New diagnostic tools for sleep and breathing and healthcare provision options - Respiratory epidemiology: from COPD to factors that associate with lung function and infections - PDW5 Teamability: become an effective team leader and member - Critically ill patients: prognostic factors and biomarkers - Preclinical and clinical studies of critical illness - Muscles and diaphragm, and quality improvement - Non-invasive ventilation for acute respiratory failure - Non-invasive ventilation in chronic respiratory failure - New tools for managing respiratory failure - New methods and concepts in tests of lung and respiratory muscle function - The value of lung function testing in various pathophysiological conditions - Cardiopulmonary exercise testing in COPD and cardiovascular diseases - New methods and concepts in exercise testing - From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS) - Diagnostics including questionnaires - Sleep-disordered breathing: biomarkers and genetics and the role of hypoxia, insomnia, movement disorders and sleep quality - Obesity: comorbidities - Pleural effusions, infections and tumours - Moving lung transplantation forward - Predicting the future: biomarkers of respiratory infection - Pneumonia: from the community to the intensive care unit - Mechanisms of respiratory infection - Improving the quality of life of patients with bronchiectasis - Challenges in tuberculosis care - Tuberculosis comorbidities - Groups who are susceptible to tuberculosis: children, pregnant women and elderly people - Pulmonary tuberculosis: long term complications, rehabilitation and challenges - Lung cancer: new tools for diagnosis and patient assessment - Lung cancer: novel prognostic markers and scores - Lung cancer: modern therapies and beyond - Lung cancer: risk factors, supportive measures and quality improvement - Lung cancer: from the bench to the bedside - Mesothelioma and pleural malignancy: investigations and management - Clinical management of pleural malignancies, including mesothelioma - Consequences of idiopathic interstitial pneumonias - News on the diagnosis of idiopathic interstitial pneumonia - Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF) - CTD-ILD and hypersensitivity pneumonitis:  mechanistic insights and prognostic markers - Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment - Granulomatous disorders: heterogeneous diseases with variable management - Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) - Pulmonary hypertension: therapy - Experimental research in pulmonary hypertension - Clinical aspects of pulmonary hypertension - Pulmonary hypertension in lung diseases and the role of the right ventricle - Diagnosis, prognostication and treatment of pulmonary embolism - Medical education via the web and the internet - COPD, asthma and tuberculosis: benefits related to therapy costs - New biologics for asthma: which patients, which agents, which results, at what cost? - Airway Diseases & Respiratory Infections - Paediatric Respiratory Diseases - ME7 Monitoring of home mechanical ventilation in neuromuscular disorders - PF Occupational lung disease – professional and patient perspectives - ME8 Diagnosing bronchiectasis and cystic fibrosis - ME6 Control of breathing - hypoventilation during sleep, exercise and dyspnoea - ME5 Lung cancer screening - ME14 Bronchiolitis obliterans syndrome in immunodepressed patients - SW9 Cardiopulmonary exercise test interpretation - tips and pitfalls FULLY BOOKED - SW12 Thoracic ultrasound FULLY BOOKED - PDW6 Supporting patients with behaviour change strategies - Chronic pulmonary aspergillosis: from guidelines to real-life implementation - Imaging chronic lung diseases: moving from structure to function  - Idiopathic pulmonary fibrosis diagnosis: new guidelines - Advances in community-acquired pneumonia management  - Roles of innate lymphoid cells in asthma - Microbiomes in respiratory disease - New methods for diagnosing and treating lung diseases - Molecular mechanisms and treatment of pulmonary hypertension - The best of the European Respiratory Journal in 2018 - Pathophysiological aspects of sleep-disordered breathing: intermittent hypoxia - Ventilation and lung imaging in critically ill patients - Lung cancer: new aspects in diagnosis and management - Recent insights in childhood asthma and wheezing - Pulmonary hypertension: right ventricle function, haemodynamics and exercise - Lung transplant science: from primary graft to chronic allograft dysfunction - What’s new in lung function and exercise assessment in COPD? - Exercise is medicine: testing and treating patients with some effort - Cryobiopsy in interstitial lung disease (ILD) - Innovations in equipment and their application - Latest developments in cystic fibrosis - Ensuring impactful independent education - CC6 Interstitial lung diseases  - CC7 Severe asthma - CC8 Non-resolving pneumonia - Pulmonary endoscopy - State of the art session: Respiratory critical care - Proteases: at the cutting edge of lung disease - GINA 2018 and beyond: shaping the future of asthma management - Accelerated ageing in lungs - Prenatal origins of respiratory and atopic disorders - New perspectives on asthma, cough and laryngeal obstruction - Notable Studies in Asthma - Microorganisms and lung ecology: living in peace with bugs - Biomarkers in COPD and asthma - New ideas about respiratory and sleep physiology in children - Acute pulmonary embolism: from diagnosis to treatment - Paediatric respiratory infections: translational and clinical perspectives - Interdependence of COPD and comorbidities and the underlying mechanisms - Muscle adaptations in response to physiotherapeutic interventions in acute and chronic settings - Additional latest insights in pulmonary rehabilitation for chronic lung diseases - CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside - Drug-resistant tuberculosis - Asthma analysis - Novel insights in the basic and translational research on idiopathic interstitial pneumonias - SW19 Clinical interpretation of spirometry results FULLY BOOKED - SW17 Essential skills for the intensive care unit - SW14 Radiological-pathological correlations in different lung diseases for clinicians FULLY BOOKED - Pulmonary endoscopy - Scientific Year in Review - It's my favourite cell that affects your asthma - Recent advances in respiratory disorders with oropharyngeal dysphagia - Fungal infection in the intensive care unit - Recent advances in primary ciliary dyskinesia - Quality, reference values and standards - Progress in rare interstitial lung diseases - New challenges in tackling known diseases with the 10 ERS Principles for Lung Health - Imaging biomarkers and quantitative imaging - Pulmonary embolism: long-term sequelae and advances in therapies  - Novel findings in biomarkers of tobacco use, exposure, hazards and genetics - CTD-ILD and hypersensitivity pneumonitis: risk stratification and management - Telehealth, home rehabilitation and specific adaptations to exercise interventions in different settings - General thoracic surgery - How far are we in terms of predicting mortality and exacerbations in COPD? - Current practices in and attitudes to screening for tuberculosis, and a discussion about genetic diversity - New insights in testing lung and respiratory muscle functions - Asthma and allergy in adults and children and their biomarkers - Pathobiology of pulmonary hypertension - Tests and trends in asthma - Asthma and drugs - Clinical markers of asthma - Patient-reported outcomes and scores in COPD - COPD and extrapulmonary comorbidities - Functional assessment of COPD - Biomarkers of COPD - COPD exacerbations and bronchiectasis - Sarcoidosis, interstitial lung diseases and various clinical problems - Pulmonary rehabilitation: exercise training, body composition, physical activity and other aspects - Aspects of pulmonary rehabilitation and chronic care - Use of stents for tracheal stenosis - Bronchoscopy and transthoracic ultrasound - Primary care management of asthma - Genetics in chronic pulmonary diseases - COPD: immune regulation and therapeutic targets - COPD: novel pathological mechanisms in the airway epithelium - Role of microbial exposure and inflammation in lung injury - Triggers of acute lung injury: mechanical ventilation and oxygen levels - Cardiovascular and metabolic consequences of sleep-disordered breathing - Treatments that can serve as an alternative to positive airway pressure (PAP) - Sleep and breathing control: phenotypes - COPD management - Studies on the mechanisms underlying airway disease - Airway disease: recent discoveries - Clinical and functional monitoring in airway disease - Asthma, rhinitis and COPD: cells, mediators, biomarkers and genetics - Epidemiology of asthma, COPD and factors that associate with lung function - Respiratory epidemiology:  from infectious diseases to lung cancer - Occupational and environmental lung diseases: inhaled air quality and health effects - Epidemiology of the use of traditional and emerging tobacco products and e-cigarettes - Tobacco use, attitudes and cessation training among healthcare professionals and prevention programmes - Improvements in the assessment of paediatric physiology - Paediatric asthma: new insights in its prevalence, treatment and treatment failure - Cystic fibrosis in paediatric patients: current research  - Paediatric respiratory infections: mechanistic insights and clinical outcomes - Neonatology and paediatric intensive care - Insights in primary ciliary dyskinesia, asthma and lung function testing - Clinical challenges in respiratory infection - Difficult-to-treat respiratory infections - The immune response to tuberculosis: development of biomarkers and diagnostic tools - Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis - Diagnosis of tuberculosis - Management of idiopathic interstitial pneumonias: established and new treatments - Back to basics and translational research in idiopathic interstitial pneumonias - Bronchiectasis: new insights in diagnosis and treatment - Sleep and Breathing Disorders - Myths and Truths of Inhaler Technology - Respiratory Infections - ME9 Cryobiopsy in interstitial lung disease FULLY BOOKED - Pulmonary Vascular Diseases & Respiratory Infections - ME11 Management of severe asthma in children - ME10 Pulmonary arterial hypertension: treatment options FULLY BOOKED - ME12 Immunotherapies for lung cancer - ME13 Management of pulmonary and critical care disease during pregnancy - SW20 Clinical interpretation of spirometry results - SW18 Essential skills for the intensive care unit - SW15 Radiological-pathological correlations in different lung diseases for clinicians - Clinical Grand Round  - State of the art session: Interstitial lung diseases - The digital ®evolution in respiratory medicine: a personalised approach? - Pathophysiology of the human lung alveolus - Emerging tobacco products and harm reduction: a tobacco solution to a tobacco problem? - Lung cancer screening and management of solitary pulmonary nodules - Advanced profiling of immune cells in chronic lung diseases - Interventional pulmonology highlights in 2018: ELVR, TLD and BT See this session or publication
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Congress or journal article abstract Study of diagnostic sensitivity for mycobacterium tuberculosis(MTB) by smear, culture and Xpert MTB/RIF assay in pleural specimens obtained by medical thoracoscopy.
M. Prasad (Bengalure (Karnataka State), India)
International Congress 2018 - Chinese Programme 2018: Part I - Russian Speaking Programme 2018: Part I - PDW1 Spirometry training programme: become a programme organiser - PG2 Thoracic ultrasound FULLY BOOKED - PG5 Noninvasive ventilation - pitfalls and challenges - PG1 Asthma and chronic obstructive pulmonary disease - PG4 Imaging of the chest - PG7 Sleep-disordered breathing - diagnosis and therapy - PG8 Lung function testing - PG6 Bronchoscopy in pulmonary emergencies - PG9 Chronic obstructive pulmonary disease exacerbations - Primary Care Programme 2018: Part I - PG10 Cystic fibrosis: Basic defects and clinical problems in children  - PG11 Modern approaches in lung cancer diagnostics and therapy - PG3 How to plan for and manage a respiratory epidemic/pandemic - Russian Speaking Programme 2018: Part II - Chinese Programme 2018: Part II - Primary Care Programme 2018: Part II - French Programme 2018: Part I - Spanish and Portuguese Programme 2018: Part I - PG15 Challenging issues in acute interstitial lung diseases - PG12 Interventional pulmonology - PG14 The evolving world of pulmonary rehabilitation - PG16 Advanced cardiopulmonary exercise testing - PG17 Asthma phenotyping - PG13 Challenges in the treatment of tuberculosis - PG18 Cystic fibrosis: management in adult patients - PG19 Heart-lung interaction - French Programme 2018: Part II - Spanish and Portuguese Programme 2018: Part II - CC1 Lung transplantation - CC2 Broad spectrum of chronic thromboembolic pulmonary hypertension - SW1 Body plethysmography - Lung cancer Grand Round - State of the art session: Airways disease - New Sepsis Surviving Campaign guidelines: back to the “art of medicine” - EUREST-PLUS: implementation of the tobacco control policy to reduce lung disease - Difficult paediatric lung disease - ILDs: From bench to bedside - Risk stratification in treatment of pulmonary arterial hypertension - Organoids and pluripotent stem cells  - Respiratory muscles at rest, during exercise and in the critically ill patient - Primary care management of respiratory conditions - Asthma in children and adults: long-term aspects - Prematurity and lung disease - Evolving approaches to differential diagnosis - Epidemiology and prognostication of critically-ill patients - Paediatric asthma: prevention, diagnosis and treatment - The global impact of bronchiectasis and nontuberculous mycobacteria (NTM) - Occupational and environmental lung diseases: asthma and the airways - Evaluation of COPD and various diseases by different imaging modalities - EUS-B and EBUS: optimal utilisation of the EBUS scope - Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities - PDW2 Medical writing - SW5 Endoscopy FULLY BOOKED - SW2 Body plethysmography FULLY BOOKED - Imaging Grand Round - State of the art session: Pulmonary vascular diseases - Cournand lecture: new paradigms in extracorporeal lung assistance - Towards understanding and managing chronic cough - Dyspnoea: a multidimensional and multidisciplinary approach - Imminent global problems in lung cancer require joint action: time for an international alliance! - Mechanisms that underlie exercise limitation in various respiratory diseases - Multidisciplinary approach to ground-glass opacities - Gene-environment interactions in the omics era - Pleural disease: diagnosis, monitoring and management - A fresh view on airway differentiation and regeneration - Cystic fibrosis: microbiological aspects and new treatments - New pharmacological strategies in airway diseases - Challenges in treating tuberculosis and nontuberculous mycobacteria - Clinical news in idiopathic interstitial pneumonias - Assessing pathophysiology in children - COPD phenotypes: a1 antitrypsin deficiency and beyond - Regenerative and anti-fibrotic approaches - Innovative therapies in asthma and COPD - Orphan diseases in children - PDW3 Leading and managing change - Physiological and biological insights in asthma - Asthma: clinical screening tools - Integrated care and non-pharmacological management of COPD - Nutrition and metabolic syndrome in COPD - Cardiovascular morbidities in COPD - COPD around the world - Pharmacological management of COPD - Management of bronchiectasis and large airway diseases - Management of chronic cough and respiratory muscle dysfunction - What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)? - Imaging of various diseases with different imaging modalities - Linear and radial EBUS and peripheral nodules - Pleural interventions - Primary care management of COPD - Functional genomics and COPD: new challenges - Studying novel biomarkers in asthma and COPD - Identification of therapeutic targets for asthma - Pulmonary fibrosis: from models to patients - Pulmonary drug delivery: inhaler use, devices and technologies - New developments in the treatment of asthma - Basic pharmacology - Biomarkers for evaluating COPD - Biomarkers for evaluating asthma - Translational models of the immunopathology that underlies airway obstructive diseases - Role of IgE and interleukin (IL)-5 in Th2-cell signatures - Epidemiology of asthma and allergy: prevalence, incidence and risk factors - Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS) - Occupational and environmental lung diseases: mechanisms, biomarkers and causation - Occupational and environmental lung diseases: influence on the airway and interstitium - Tobacco use and cessation interventions in patients with respiratory, cardiovascular and mental health problems and other populations - Effect of tobacco use on health - Role of omics in population studies - The bad and the ugly in paediatric asthma: comorbidities and exacerbations - Paediatric asthma: new mechanisms and tools - Cystic fibrosis in adults: current research - Clinical problems in paediatric pulmonology - Paediatric bronchology - Molecular and cellular determinants of the developing lung - Respiratory physiology and measurements - Acutely hospitalised patients: physiotherapy interventions and assessment methods - Chronic lung disease : effects of rehabilitation interventions on functional outcomes in patients - Chronic respiratory disease: respiratory muscle function, breathing exercises and airway clearance techniques - Chronic respiratory disease : determinants of physical activity in patients - Chronic respiratory disease: effects of rehabilitation interventions in patients - Contemporary respiratory care: symptoms, the role of the nurse and the organisation of care - Advances in idiopathic pulmonary fibrosis treatment, tracheobronchial reconstruction using bioengineering and clinical prediction rules for diagnosing pulmonary embolism - Interstitial Lung Diseases & Respiratory Infections - ME1 Endoscopic lung volume reduction FULLY BOOKED - ME2 Lung microbiome: study design and standardisation FULLY BOOKED - ME4 Mucus clearance techniques across respiratory care settings - ME3 Bronchoscopic evaluation of recurrent/persistent pneumonia in children - SW6 Endoscopy - SW3 Body plethysmography FULLY BOOKED - PDW4 How to deal with difficult employees and co-workers - Paediatric Year in Review - State of the art session: Sleep and breathing disorders - Current and evolving tests in lung function: pro/con debate - Air pollution and transplantation: near to one's heart and lungs! - Interstitial lung disease: an interdisciplinary approach - Management of pleural infection in 2018 - Best abstracts in pulmonary rehabilitation and chronic care - Cleaning agent exposures: are they really harmful to lung health? - Mitochondrial dysfunction as a driver of lung disease - On the right path: understanding and improving the function of an overloaded right heart ventricle - Educational tools to improve your practice - Novel immunology-based therapies in asthma and COPD - Clinical trials in COPD: new results - New insights in the management of chronic respiratory failure - Variant forms of asthma - Asthma management - Respiratory muscle function, postural control and breathing exercises in chronic respiratory conditions - Systematic reviews on the health effects of emerging tobacco products and electronic nicotine delivery systems (ENDS) - Thoracic surgery, pleural effusions and other general thoracic surgery - Lung cancer: from early diagnosis to modern monitoring strategies - CC3 Lung cancer: personalised treatment and palliative care  - CC4 Tuberculosis - CC5 Pulmonary vasculitis: the great chameleon - SW7 Cardiopulmonary exercise test interpretation - tips and pitfalls FULLY BOOKED - SW10 Thoracic ultrasound FULLY BOOKED - Paediatric Grand Round - State of the art session: Thoracic oncology - Therapeutic breakthroughs Year in Review - New trends in the management of difficult-to-wean patients  - Sleep apnoea: is it time for new therapies? - Rare lung diseases - New modalities in asthma treatment - Pulmonary embolism: what we need to know - Cross-talk in the lung microenvironment: implications for chronic lung disease - COPD and chronic respiratory disease: from misclassification to radiological findings - Novel drug targets for asthma and COPD - Occupational and environmental lung diseases: from early influences and novel exposures to preventative approaches - New developments in tuberculosis - Pleural diseases and pneumonia: what's new ? - Determinants of physical activity behaviour in patients with COPD and the physiotherapist as a physical activity coach  - Integrating pharmacological and non-pharmacological management in COPD: are we there yet? - Clinical determinants and biomarkers of COPD - Improving the outcomes of community-acquired pneumonia - Let’s interact and discuss the hot topics in pulmonary rehabilitation - The many facets of respiratory nursing - SW8 Cardiopulmonary exercise test interpretation - tips and pitfalls FULLY BOOKED - SW11 Thoracic ultrasound FULLY BOOKED - Clinical Year in Review - State of the art session: Respiratory infections - Infectious agents and childhood asthma - Preventing asthma and COPD exacerbations by increasing the inhaled glucocorticoid dose - Integrated care for patients with pulmonary vascular disease, lung diseases and heart failure - Respiratory medicine meets hematology - Intercellular communication in tissue remodelling - COPD: from LABA/ICS to LABA/LAMA/ICS - Cell-matrix interactions in lung disease and regeneration - New predictors of morbidity and mortality in COPD - Respiratory muscles and lung function: from healthy subjects to patients - Granulomatous disorders: epidemiology, genotype and phenotype - Interventional pulmonology highlights in 2018: latest innovations - New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases - Multiomics studies in epidemiology: what can they tell us? - The world of idiopathic pulmonary fibrosis (IPF): global registries - Lung cancer: personalised medicine - New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children - New diagnostic tools for sleep and breathing and healthcare provision options - Respiratory epidemiology: from COPD to factors that associate with lung function and infections - PDW5 Teamability: become an effective team leader and member - Critically ill patients: prognostic factors and biomarkers - Preclinical and clinical studies of critical illness - Muscles and diaphragm, and quality improvement - Non-invasive ventilation for acute respiratory failure - Non-invasive ventilation in chronic respiratory failure - New tools for managing respiratory failure - New methods and concepts in tests of lung and respiratory muscle function - The value of lung function testing in various pathophysiological conditions - Cardiopulmonary exercise testing in COPD and cardiovascular diseases - New methods and concepts in exercise testing - From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS) - Diagnostics including questionnaires - Sleep-disordered breathing: biomarkers and genetics and the role of hypoxia, insomnia, movement disorders and sleep quality - Obesity: comorbidities - Pleural effusions, infections and tumours - Moving lung transplantation forward - Predicting the future: biomarkers of respiratory infection - Pneumonia: from the community to the intensive care unit - Mechanisms of respiratory infection - Improving the quality of life of patients with bronchiectasis - Challenges in tuberculosis care - Tuberculosis comorbidities - Groups who are susceptible to tuberculosis: children, pregnant women and elderly people - Pulmonary tuberculosis: long term complications, rehabilitation and challenges - Lung cancer: new tools for diagnosis and patient assessment - Lung cancer: novel prognostic markers and scores - Lung cancer: modern therapies and beyond - Lung cancer: risk factors, supportive measures and quality improvement - Lung cancer: from the bench to the bedside - Mesothelioma and pleural malignancy: investigations and management - Clinical management of pleural malignancies, including mesothelioma - Consequences of idiopathic interstitial pneumonias - News on the diagnosis of idiopathic interstitial pneumonia - Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF) - CTD-ILD and hypersensitivity pneumonitis:  mechanistic insights and prognostic markers - Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment - Granulomatous disorders: heterogeneous diseases with variable management - Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) - Pulmonary hypertension: therapy - Experimental research in pulmonary hypertension - Clinical aspects of pulmonary hypertension - Pulmonary hypertension in lung diseases and the role of the right ventricle - Diagnosis, prognostication and treatment of pulmonary embolism - Medical education via the web and the internet - COPD, asthma and tuberculosis: benefits related to therapy costs - New biologics for asthma: which patients, which agents, which results, at what cost? - Airway Diseases &